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Heme is a prosthetic group in proteins that perform diverse biological functions including 
respiration, gas sensing, xenobiotic detoxification, cell differentiation, circadian clock 
control and micro RNA processing. In most eukaryotes, heme is synthesized through a 
multi-step pathway with defined intermediates that are highly conserved through 
evolution. Despite our extensive knowledge about heme biosynthesis and degradation, 
the molecules and pathways involved in intracellular heme trafficking are unknown, 
primarily due to the inability to dissociate the tightly regulated processes of heme 
biosynthesis and degradation from intracellular trafficking events. Caenorhabditis 
elegans and related helminths are natural heme auxotrophs that rely solely on exogenous 
heme for normal development and reproduction. We performed a genome-wide 
microarray analysis and identified 288 genes that are regulated by heme at the 
transcriptional level in C. elegans. Here, we characterize two heme-responsive genes, 
hrg-1 and its paralog hrg-4, that are highly upregulated at low heme concentrations and 
  
demonstrate that HRG-1 and HRG-4 are heme transporters. Depletion of hrg-1 and hrg-4 
in worms by RNAi results in the disruption of organismal heme homeostasis and 
abnormal response to heme analogs. HRG-4 traffics to the plasma membrane, and HRG-1 
localizes to endo-lysosomal compartments. While hrg-4 appears to be specific to worms, 
hrg-1 has homologs in vertebrates. Knock-down of hrg-1 in zebrafish results in severe 
anemia and profound developmental defects, which are fully rescued by worm hrg-1. 
Human and worm HRG-1 proteins localize together. CeHRG-1, hHRG1 and CeHRG-4 
all bind and transport heme.  To further understand the in vivo functions of hrg-1 and 
hrg-4, we characterize the genetic deletions of these genes in C. elegans.  Preliminary 
experiments suggest that the deletion mutants respond abnormally to heme analogs, 
although these results do not phenocopy the RNAi knock-down studies.  We speculate 
that the deletion strains may have developed compensatory mechanisms in response to 
the genetic lesions in hrg-1 and hrg-4.  Taken together, the studies described herein lay 
the foundation for identifying the molecular mechanisms for heme transport by the HRG-
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Chapter 1 Introduction 
Iron, one of the most abundant transition metal present in the Earth, is also a 
critical micronutrient. With its ability to readily accept and donate electrons, it 
participates in a wide variety of biochemical reactions as an oxidant or reductant. Iron 
deficiency is a major diet-related health problem world-wide [1]. Iron-deficiency 
anemia affects up to two billion people and can exacerbate other health problems. 
Iron deficiency impairs physical and mental development in children. In developing 
countries, serious complications from nutritional iron deficiency are compounded by 
malaria and hookworm infestations. Hookworms cause anemia by feeding on blood 
from lacerated capillaries in the intestinal mucosa. The malarial parasite, Plasmodium 
falciparum, contributes to the etiology of anemia through several mechanisms 
including direct destruction of parasitized red blood cells, reduction in iron absorption 
due to increased parasite load and even sequestration of iron by the parasite. As a 
result, therapeutic regimens for treating both hookworm infections and malaria 
include iron supplements [2-5]. 
Despite being one of the Earth’s most abundant metals, iron-deficiency 
anemia is a major health risk factor in both developed and developing countries for 
two reasons. The first reason for such high incidence of iron deficiency anemia is 
that, under physiological pH, elemental Fe (II) oxidizes to Fe (III), which then 
precipitates to form ferric hydroxide or hydroxyl-iron dimers that are absorbed poorly 
by the small intestine. The second reason is that plant compounds such as tannins and 
phytates can chelate free iron to form insoluble complexes that prevent iron 
absorption [6].  By contrast, heme, or iron-protoporphyrin IX, is more readily 
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absorbed than inorganic iron and is the source for two-thirds of body iron even 
though heme constitutes only one-third of total dietary iron [7, 8]. This can be 
attributed to the fact that heme is soluble in the alkaline pH of the small intestine 
where most absorption occurs and heme uptake is not influenced by plant compounds 
that interfere with iron absorption [9]. Despite the importance of heme as a dietary 
source of iron, the mechanism by which heme absorption occurs through the 
intestinal cells is poorly understood. While biochemical studies have shown that heme 
is absorbed via the brush border present on the enterocytes, the proteins responsible 
for heme uptake are unclear [10-12]. 
Heme is a prosthetic group of proteins that perform diverse functions such as 
oxygen transport (globins), xenobiotic detoxification (cytochrome P450s), oxidative 
metabolism (cytochrome c oxidase), gas sensing (guanylate cyclases), circadian 
rhythm (nuclear hormone, Rev-erb α) and thyroid hormone synthesis 
(thyroperoxidase) [13]. Heme has also been shown to directly regulate processes such 
as cell differentiation and gene expression [14, 15]. It has also been proposed that 
heme may function as an acute cell-signaling molecule because it has been shown to 
bind the large-conductance calcium-dependent Slo1 BK channels (a class of ion 
channel) with high affinity [16]. Heme is synthesized through a highly conserved, 
eight-step pathway in most prokaryotes and eukaryotes. Tight control of cellular 
heme level is achieved by maintaining a balance between heme biosynthesis and 
catabolism by the enzyme heme oxygenase.  
Although heme biosynthesis and its regulation have been extensively studied, 
very little is known about the intracellular trafficking of heme. Once heme is 
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synthesized, it has to be transported across the mitochondrial inner membrane for 
incorporation into cytochromes present in the mitochondrial intermembrane space. 
Also, heme has to be transported out of the mitochondria to be incorporated into 
hemoproteins found in the cytosol, nucleus, endoplasmic reticulum and other 
organelles. Free heme is hydrophobic and cytotoxic due to its inherent peroxidase 
activity [17]. Thus, a prima facie argument can be made that specific molecules and 
pathways exist to transport heme from the site of synthesis to other cellular 
compartments where hemoproteins are present. 
Heme biosynthesis 
 
Heme is synthesized in most eukaryotic cells via a series of eight highly 
conserved enzymatic steps. The first step in the heme biosynthetic pathway is the 
condensation of succinyl CoA and glycine to form 5-aminolevulinic acid (ALA) 
catalyzed by ALA synthase (ALA-S). This reaction occurs in the matrix of the 
mitochondria. ALA is transported out of the mitochondria to the cytosol for the 
subsequent four steps of heme biosynthesis. ALA dehydratase (ALA-D) converts 2 
molecules of ALA to porphobilinogen (PBG), an intermediate with only one pyrrole 
ring. Porphobilinogen deaminase catalyzes the conversion of 4 molecules of PBG to 
an unstable polymer hydroxymethylbilane and uroporphyrinogen synthase (UPO-S) 
converts hydroxymethylbilane to uroporphyrinogen III (UPO III), a cyclic 
tetrapyrrole. In the next step, UPO III is decarboxylated by uroporphyrinogen 
decarboxylase (UPO-D) to form coproporphyrinogen III (CPO III). CPO III is 
transported into the mitochondria, where coproporphyrinogen oxidase (CPO), an 
enzyme found in the mitochondrial intermembrane space, catalyzes the formation of 
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protoporphyrinogen IX (PPO IX). In the final step, ferrochelatase (FECH) catalyzes 
the insertion of ferrous iron into the protoporphyrin IX (PPIX) ring to form 
protoheme or heme b (Figure 1).   
Heme b is modified at the C-2 and C-8 positions to form heme a, the form of 
heme that is found in cytochrome oxidases [18]. These modifications occur in two 
steps involving heme o synthase and heme a synthase. Heme c is found in 
cytochromes c1 and cytochrome c. Heme c differs from heme b in that heme c binds 
proteins covalently through the two vinyl side chains [19].  
The universal precursor of heme biosynthesis, 5-aminolevulinic acid (ALA), 
is synthesized from succinyl CoA and glycine in most eukaryotes but in some 
prokaryotes and all higher plants, ALA is synthesized via the glutamate C-5 pathway 
[20]. ALA synthesis occurs in three steps. Glutamate is converted to glutamyl-tRNA. 
Glutamate-1-semialdehyde is synthesized from glutamyl-tRNA by glutamyl-tRNA 
reductase. Glutamate-1-semialdehyde amino-transferase catalyzes the conversion of 
glutamate-1-semialdehyde to 5-aminolevulinic acid (ALA), after which the heme 
biosynthetic pathway is similar to its mammalian counterpart. Higher plants 
synthesize four major tetrapyrrole compounds and they are heme, siroheme, 
chlorophyll and phytochromobilin [21, 22]. Uroporphyrinogen III is the branch point 
for pathways leading to the synthesis of these different tetrapyrrole molecules. 
Methylation of UPO III and the subsequent insertion of iron (Fe+2), results in the 
formation of siroheme. Protoporphyrin IX is synthesized in plants in a manner similar 
to other eukaryotes. Insertion of Fe+2 into PP IX is the final step in heme biosynthesis, 




Figure 1. Heme biosynthesis in eukaryotes 
Heme biosynthesis is an eight-step enzymatic pathway that begins with the synthesis 
of ALA in the mitochondria. ALA is then transported from the mitochondria into the 
cytosol where the subsequent four steps occur. The intermediate coproporphyrinogen 
III is transported back into the mitochondria for the final three steps. The final step is 
the insertion of ferrous iron into the protoporphyrin IX ring and this reaction is 
catalyzed by ferrochelatase. Mitochondrial enzymes are in green and cytosolic 





































Regulation of heme biosynthesis 
 
Heme biosynthesis is regulated by several factors including iron availability, 
oxygen and by heme levels and has been extensively studied in many model 
organisms. In the bacterium Bradyrhizobium japonicum, heme biosynthesis is tightly 
coordinated with iron availability [23]. It has been shown that mutations in the Iron 
Response Regulator (irr) gene resulted in accumulation of toxic levels of porphyrin, 
and increased expression of hemB, or ALA dehydratase, an iron-dependent enzyme in 
the heme biosynthetic pathway that encodes ALA-D, under iron-limiting conditions 
in B. japonicum. Bacteria carrying the mutations in irr also had a deficiency in high 
affinity iron transport indicating that Irr might also play a role in maintaining cellular 
iron levels. Irr was found to accumulate only in conditions when iron was limiting 
and turned over rapidly when there was an abundant supply of iron. These results 
suggested that Irr is involved in iron homeostasis and the coordination of heme 
biosynthesis with iron availability [23].  
A previous study in Saccharomyces cerevisiae (baker’s yeast) showed that 
when oxygen levels fall below submicromolar concentrations, heme synthesis 
declines [24]. It has been shown in baker’s yeast that transcription of HEM13; a gene 
that encodes for coproporphyrinogen III oxidase, is repressed by heme and oxygen 
[25, 26]. While in S. cerevisiae heme is used as a measure of oxygen supply, in 
fission yeast Schizosaccharomyces pombe, sterol regulatory element binding protein 
(SREBP or Sre1p), an oxygen sensor, monitors sterol synthesis as an indirect 
measurement of oxygen supply [27]. Sre1p is an oxygen-dependent transcription 
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factor that allows for adaptations of S. pombe when oxygen levels are fluctuating. A 
transcriptional profiling study done in wild-type and ∆sre1p S. pombe during 
anaerobiosis identified heme biosynthesis genes as some of the primary targets of 
Sre1p [27]. The authors have shown significant induction of three of the heme 
biosynthetic genes, coproporphyrinogen III oxidase, protoporphyrinogen oxidase and 
ferrochelatase in mutants of S. pombe lacking Sre1p.  
All of the genes encoding for mammalian heme biosynthetic pathway 
enzymes have been cloned and studied extensively. Two different genes encode for 
the first enzyme of heme biosynthesis, ALA synthase [28]. ALA-S1 is expressed 
ubiquitously and is encoded for by the ALA-S1 gene present on chromosome 3. ALA-
S2 on the X chromosome, encodes for the erythroid-specific ALA-S2. It is not 
surprising that the regulation of these genes is also very different. Expression of ALA-
S1 is regulated by the transcription factor NPAS2, a neuronal Pas domain region 2 
protein, which also plays an important role in the circadian clock[29]. Heme-bound 
NPAS2 heterodimerizes with BMAL1; this complex binds to the ALA-S1 promoter, 
thereby upregulating heme biosynthesis [29]. Increased levels of heme in the cell 
induce heme oxygenase. Degradation of heme results in the formation of carbon 
monoxide, biliverdin and iron. In the presence of carbon monoxide, the transcription 
factor complex NPAS2-BMAL1 cannot bind DNA, thus preventing the expression of 
ALA-S1 [29].  
It has also been shown that transcription of ALA-S1 is upregulated by 
peroxisome proliferator-activated coactivator 1α, PGC-1α [30]. Ιnteractions of PGC-
1α with NRF-1 (nuclear regulatory factor) and FOXO1 (a fork head family member), 
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both of which bind the ALA-S1 promoter, are important for the activation of the ALA-
S1 promoter. Even though high intake of glucose has been used as a treatment for 
porphyrias such as acute intermittent porphyria (AIP), the mechanism by which 
glucose helped alleviate the symptoms of AIP was not understood. This study was the 
first to reveal a link between glucose metabolism and heme homeostasis.  
Han et al have shown that ALAS-2 is transcriptionally regulated by histone 
acetyltransferase p300 in erythroid cells [31]. Erythroid-specific transcription factor 
GATA1 recruits the transcriptional regulator, and the interaction between these two 
proteins induces the ALAS-2 promoter. In murine erythroleukemia cells, the 
regulation of translation ALA-S2 occurs in an iron-dependent manner by the Iron 
Responsive Element/ Iron Regulatory Protein (IRE/ IRP) system. Of the two forms of 
IRP, only IRP2 has been shown to regulate ALA-S2 [32]. Under iron-depleted 
conditions, IRP2 binds IRE in the 5’ untranslated region of ALA-S2 mRNA, inhibits 
translation and prevents heme synthesis [33].  
ALA dehydratase is the second enzyme in heme biosynthesis and catalyzes 
the conversion of ALA to PBG. There are no known tissue-specific isozymes for 
ALA-D. A single ALA-D gene in humans is located on chromosome 9. This gene 
consists of two alternatively spliced non-coding exons (1A and 1B) and eleven coding 
exons. Although the level of ALA-D is higher in the erythroid cells than all other cell 
types, there are only very subtle differences in the 5’ untranslated regions between the 
ubiquitous and erythroid-specific ALA-D. While the housekeeping promoter is located 
upstream from exon 1A, the erythroid-specific promoter is found between exons 1A 
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and 1B. It has been shown that the promoter of erythroid-specific ALA-D has GATA1 
binding sites [34].  
PBG-D, the third enzyme in the biosynthesis of heme exists as two different 
isoforms; one expressed ubiquitously and the other expressed only in erythroid cells. 
The two different isoforms are encoded by one PBG-D gene found on chromosome 
11. Two different promoters control the expression of “housekeeping” and erythroid-
specific forms of PBG-D.    
Uroporphyrinogen III is decarboxylated to coproporphyrinogen III (CPO III) 
by uroporphyrinogen decarboxylase (URO-D). Despite the marked increase in the 
level of URO-D mRNA in erythroid cells, the molecular mechanisms for this 
upregulation are unclear. Coproporphyrinogen oxidase found on the mitochondrial 
intermembrane space catalyzes the conversion of CPO III to protoporphyrinogen IX 
(PPO IX). Both oxygen-dependent and oxygen-independent forms of this enzyme 
exist. Eukaryotes and some prokaryotes utilize the oxygen-dependent form of CPO. 
The promoter of human CPO gene has a Sp-1 like element, GATA-1 binding site and 
a novel regulatory element, all of which interact to upregulate the expression of CPO 
in erythroid cells [35]. The enzyme that converts PPO IX to protoporphyrin IX (PP 
IX) is protoporphyrinogen oxidase (PPO). The gene resides on chromosome 1 and the 
5’ flanking region contains a GATA-1 binding site, suggesting a possible regulation 
by GATA-1 in erythroid cells [34].  
Ferrochelatase (FECH), the last enzyme in the biosynthesis of heme, catalyzes 
the addition of iron into PP IX.  The crystal structure of FECH revealed that the 
enzyme functions as a homodimer and that there is a potential binding site for an iron 
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donor protein on the matrix side of the homodimer [36, 37]. It has been shown that 
frataxin, a nuclear-encoded protein targeted to the mitochondrial matrix, important for 
mitochondrial iron metabolism, interacts with ferrochelatase. This interaction results 
in the transfer of iron from frataxin to FECH [38]. Taketani et al demonstrated that 
expression of ferrochelatase is regulated by intracellular iron levels through the iron-
sulfur cluster that resides at the carboxyl-terminus of the enzyme [39]. FECH has 
been shown to be upregulated under hypoxia [40]. FECH has two Hypoxia Inducible 
Factor-1 binding sites, and, therefore, it is possible that the increase in level of FECH 
expression is due to a mechanism that involves HIF-1 [40].   
 
Pathology of heme biosynthesis 
 
Defects in any of the heme biosynthetic pathway enzymes, except ALA-S2, are 
clinically known as porphyrias. The classification of porphyrias is based on the site of 
defect (hepatic versus erythropoietic) and by the enzyme that is defective [41]. Most 
porphyrias result in accumulation of porphyrin intermediates. While symptoms vary 
depending on the type of porphyria, some of the major symptoms associated with 
porphyria include abdominal pain, light sensitivity (photodermatitis) and neuro-
muscular symptoms such as muscle pain, muscle weakness or paralysis and numbness 
or tingling sensations [42].   
Mutations in ALA-S2 lead to sideroblastic anemias. This type of anemia is 
characterized by excessive deposits of non-heme iron within the mitochondria of a 
pathologic erythroid precursor.  
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The most common hereditary hepatic porphyria is known as acute intermittent 
porphyria (AIP). AIP, an autosomal dominant disorder, occurs due to the deficiency 
of both the ubiquitous housekeeping and erythroid-specific isoforms of 
porphobilinogen deaminase (PBG-D). Gastrointestinal and neuropathic symptoms 
such as abdominal pain and paralysis are characteristic of AIP.  
An extremely rare disease called congenital erythropoietic porphyria or 
Gunther’s disease results from mutations in uroporphyrinogen synthase. Anemia 
occurs as a result of a shortened life span of red blood cells, and symptoms can 
occasionally appear during infancy [43]. Defects in protoporphyrinogen oxidase lead 
to variegate porphyria. This porphyria is characterized by skin photosensitivity and 
skin eruptions on exposure to sun due to accumulation of porphyrins [41].  
A deficiency in uroporphyrinogen decarboxylase (URO-D) causes porphyria 
cutanea tarda (PCT). This disease is most often acquired, but, in some individuals 
PCT develops due to inheritance of autosomal dominant deficiency of URO-D [44]. 
This is one of the hepatic porphyrias and large amounts of porphyrins build up in the 
liver when the disease becomes active. Factors such as iron deficiency and alcohol 
use influence PCT disease progression. PCT is the most treatable of porphyrias. 
Removal of blood or a phlebotomy to reduce iron load is the most recommended form 
of treatment.  
Deficiency of ferrochelatase activity results in erythropoietic protoporphyria 
(EPP), also known as protoporphyria. Patients with this disorder have reduced 
enzyme activity and accumulate protoporphyrin in their hepatic cells, which leads to 
hepatic failure. This disease is also characterized by severe photosensitivity [44]. Oral 
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administration of beta-carotene, vitamin A precursor and a natural plant product, has 
been the most effective treatment as it reduces the symptoms of photosensitivity [43].  
 
Degradation of heme 
 
 While heme that is synthesized in most eukaryotic cells is used for 
incorporation into hemoproteins that perform diverse biological functions, heme is 
also absorbed by enterocytes as a dietary source of iron. Once heme bound to 
hemoglobin is absorbed through the intestine, it is broken down to biliverdin, CO and 
iron in two steps. The first step is breakdown of heme by the microsomal enzyme 
heme oxygenase (HO), into bilirubin [45]. The second step of the heme degradation 
pathway is the catalysis of bilirubin to biliverdin, CO and iron by biliverdin 
reductase.  
Heme oxygenase also catalyzes the breakdown of free heme that is not bound 
to any protein, acting as a scavenger to prevent the toxicity from free heme. Two 
different genes encode two isoforms of heme oxygenase HO-1, the inducible form 
and HO-2, which is constitutively expressed [46]. HO-3, a third isoform of heme 
oxygenase, is brain-specific and exhibited very poor heme degradation activity when 
expressed in E. coli [47]. Results from Hayashi et al showed that HO-3 is a 
pseduogene arising from HO-2 because of the presence of stop codons within the 
coding region of HO-2 and the lack of HO-3 mRNA and protein expression in rat 
tissues.  
Although HO enzymes are present in abundance in the ER, it has been shown 
that HO-1 associates with the plasma membrane of endothelial cells upon induction 
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by factors such as LPS and heme [48].  Nuclear translocation of HO-1 was observed 
when NIH3T3 cells were stimulated with heme, hemopexin or hypoxia [49]. 
Translocation to the nucleus requires a C-terminal truncation of HO-1 by an 
uncharacterized protease. Nuclear localization has been shown to be an important 
cytoprotective signaling mechanism during oxidative stress [49].  
Bach-1, a mammalian transcriptional repressor that is regulated by heme, 
regulates HO-1 [50]. Bach-1 is a bZIP protein that forms heterodimers with Maf 
proteins, binds to heme responsive elements (HRE) in the 5’ untranslated region of 
the HO-1 promoter and down regulates HO-1 under low heme conditions. In human 
liver cells, knock-down of BACH-1 resulted in an increase in HO-1 gene expression.  
Binding of heme to Bach-1 caused a conformational change and reduced the ability of 
Bach-1 to bind to HREs found in the promoter of HO-1. This, in turn, led to the 
binding of transcriptional activators, such as Maf and Nrf2, to HREs in the HO-1 
promoter to increase transcription of HO-1 [50]. 
HO-1 belongs to a larger family of stress proteins. Although HO-1 shares no 
homology with heat shock proteins and does not display any protein chaperone 
activity, promoter regions of HOs from different species contain heat shock elements. 
For this reason, HO-1 is also referred to as Hsp-32. In rodents, hypothermia has been 
shown to induce HO-1 protein and mRNA accumulation [51]. 
While HO has been shown to play important cytoprotective roles, the products 
of heme degradation also play key roles in several cellular processes [51]. Iron 
released from heme by HO has been thought to enter a labile or chelatable pool of 
iron and can be used for iron-dependent cellular processes [52]. Studies have also 
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shown that levels of ferritin, an iron storage protein, increased when HO-1 was 
induced [53, 54]. Ferritin synthesized due to HO-1 activity has been thought to 
contribute to HO-1-mediated cytoprotection [55]. The other product of heme 
degradation is bilirubin, a yellow pigment that is secreted into the bile and rapidly 
eliminated. Although bilirubin is eliminated from cells, it has been shown to have a 
beneficial role as an antioxidant and is still under investigation as a therapeutic agent 
for several inflammatory diseases such as vascular injury [51].  
Carbon monoxide (CO) is also generated upon degradation of heme. Despite 
its effects as an air pollutant, recent studies shed light on the physiological importance 
of CO.  CO has been shown to bind directly to heme-iron of soluble guanylate 
cyclase, thereby stimulating the enzyme and leading to subsequent elevation in cyclic 
GMP levels [56]. CO has also been shown to have anti-apoptotic and anti-
proliferative effects. CO has been known to possess vasodilation properties, and these 
dilatory effects are thought to occur by regulating cGMP levels and potassium 
channel activity [51].  
The end products of heme degradation have been examined for their 
therapeutic value. For example, application of bile pigments exogenously has been 
shown to alleviate symptoms of transplant rejection, and inhalation of CO has been 
effective in several animal models including models of inflammation, vascular injury, 





Heme uptake and transport 
 
Heme uptake and transport have been well-characterized in pathogenic 
bacteria. In order to cause infection in the host, pathogenic bacteria must satisfy their 
iron demands. As a defense mechanism against pathogens, the host must restrict 
access to iron and heme. This restriction of iron and heme to pathogens poses a 
serious problem that the bacteria must overcome for survival. While most bacteria 
secrete high-affinity, low-molecular weight chelators to sequester iron, some have the 
ability to obtain their iron requirements by binding either exogenous heme or heme-
containing proteins, or by secreting hemophores [57].  
The general mechanisms of heme acquisition in pathogenic gram-negative 
bacteria are demonstrated in Figure 2. Heme uptake systems are classified into two 
groups a) those that involve direct binding of heme or hemoproteins by specific outer 
membrane receptors and b) those that involve secretion of hemophores that bind the 
heme source and deliver it to specific receptors [57]. There are 29 outer membrane 
heme receptors that have been identified from different species of gram-negative 
bacteria. Although these receptors share between 21% and 90% homology when 
compared to each other, they all share a highly conserved amino acid motif 
FRAP(10X)H(XX)NPL(2X)E [58]. The outer membrane receptors can be divided 
into subgroups. A first subgroup of outer membrane receptors is not substrate-specific 
and binds either heme or heme-containing proteins. Such receptors are found in 
Yersinia enterocolitica, Escherichia coli and Shigella [57]. Outer membrane receptors 
such as HemR in Y. enterocolitica bind heme and transport it actively across the outer 
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membrane into the bacterial periplasm. An intact Ton system, with the cytoplasmic 
membrane proteins ExbB and ExbD and membrane-anchored protein TonB, is 
required to provide energy for heme transport across the outer membrane. The TonB 
system uses a proton-motive force for the passage of heme into the periplasm. Heme 
is bound by a periplasmic heme binding protein such as HemT and then delivered to 
permeases on the cytoplasmic membrane, like HemU and HemV in Y. enterocolitica 
[59]. Transport of heme across the cytoplasmic membrane requires expenditure of 
ATP. In the cytoplasm, HemS and HemO proteins process heme to release iron.  
 The second subgroup of receptors is substrate-specific and binds only 
one or two sources of heme. These heme receptors are found in Vibrio, Neisseria and 
Haemophilus and these receptors have a high affinity binding sites for one or two 
particular heme sources such as hemoglobin (Hb) and or haptoglobin-hemoglobin 
(Hpt/Hb) complexes [57]. The neisserial Hpt-Hb and Hb receptor, HpuAB is the only 
system with two outer membrane receptors, HpuA and HpuB. While HpuA is an 
outer membrane lipoprotein, HpuB is a TonB-dependent receptor that is similar to 
other TonB-dependent receptors. It has been shown that both proteins are required for 
Hb, Hpt-Hb and apo-haptoglobin binding. But it is not clear as to whether HpuA and 




Figure 2. Heme acquisition by gram-negative bacteria. 
Hemolysin secreted by bacteria degrades red blood cells (RBC), releasing 
hemoglobin (Hb) and heme. Once released, heme may be transported into the 
bacterial cell by different mechanisms A) direct binding of hemoglobin or heme to a 
specific TonB-dependent outer membrane receptor results in transport of heme into 
the periplasm. B) Capture of hemoproteins such as hemoglobin or hemopexin by 
hemophores, which deliver these hemoproteins to a specific TonB-dependent outer 
membrane receptor. C) Degradation of hemoproteins by either membrane bound or 
secreted bacterial proteases to release heme. Heme bound by TonB-dependent outer 
membrane receptors is transported into the periplasm. TonB in association with the 
ExbB and ExbD proteins provide energy for this process. The transport of heme 
through the cytoplasmic membrane occurs via a system composed of cytoplasmic 
membrane-associated permease and an ATPase. Heme oxygenase-like enzymes 
degrade heme in the cytoplasm. 
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 Several gram-negative bacteria secrete small extracellular proteins called 
hemophores. They are secreted by ABC transporters and this process involves their 
carboxy-terminal secretion signal [60]. Hemophores bind heme and deliver it to 
specific outer membrane receptors. One of the best-studied systems is the HasA-HasR 
mediated heme uptake in Serratia marcescens. While usually the role of hemophores 
is to bind free heme or Hb-bound heme, the hemophore, HasA, secreted by HasDEF 
in S. marcescens has been shown to extract heme from hemoproteins. The free heme 
is then delivered to the outer membrane receptor HasR [61, 62]. HasR can transport 
either free heme or heme from hemoglobin, but the presence of HasA promotes heme 
uptake to a greater extent. The mechanism of heme transfer to HasA from 
hemoglobin is not understood. It is thought that hemoglobin loses its heme moiety in 
solution, which is then bound by HasA [63].  Similar hemophore-mediated heme 
acquisition systems have been identified in Porphyromonas gingivalis and the human 
pathogenic strain of Escherichia coli [64, 65]. 
The only known bacterial system that utilizes heme bound to hemopexin 
(HPX) is the HuxA hemophore system found in Haemophilus influenzae [66]. H. 
influenzae does not make heme and the HuxABC gene cluster found in these bacteria 
allows it to utilize hemopexin, a heme-binding blood plasma protein very efficiently. 
HuxA is actively secreted by HuxB and has been shown to be absolutely required for 
the utilization of heme-HPX complexes [58]. 
Some gram-negative bacteria secrete proteases that degrade host hemoproteins 
to release heme. A heme binding protein in E. coli EB1 strain was shown to possess 
proteolytic activity, as it was able to degrade hemoglobin [66]. Porphyromonas 
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gingivalis, a gram-negative anaerobic bacterial pathogen, secretes a class of protease 
called gingipains [67]. Of the several gingipains, the lysine-specific cysteine protease 
Kgp has been shown to both bind and degrade hemoglobin, hemopexin and 
haptoglobin [66]. 
Since heme is an essential nutrient for most pathogenic bacteria, it has been 
shown that virulence of pathogenic bacteria can be affected by targeting heme uptake 
pathways. Mutations in heme-iron uptake genes in Staphylococcus aureus reduced its 
pathogenicity in the invertebrate animal model, C. elegans [68]. In Bordatella 
pertussis, the bacterial agent responsible for whooping cough in humans, heme 
utilization by the bacteria has been shown to contribute to bacterial pathogenesis in 
the mouse infection model [69].  
While several bacterial heme uptake and transport systems have been well-
characterized, only recently have proteins involved in heme uptake been identified in 
eukaryotes. In pathogenic yeast, Candida albicans, RBT5 and RBT51 have been 
identified as heme uptake genes. Rbt5 and Rbt51 are mannosylated proteins, and Rbt5 
is highly induced upon iron starvation [70]. Despite 70%  homology between the two 
genes in C. albicans, RBT5 played a more important role than RBT51 in utilization of 
heme as an iron source. Disruptions in these genes did not reduce the virulence of C. 
albicans in murine models [71]. C. albicans possess a heme-oxygenase enzyme 
(CaHMX1) that shares 25% identity with the human HO and CaHMX1 has been 
shown to be positively regulated by both heme and hemoglobin [72]. Whether heme-
iron utilization is essential for pathogenicity would be best addressed by using 
mutants such as Cahmx1∆ or Cahmx1∆ and CaRbt5∆ double mutants, that are devoid 
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of the ability to use the heme as an iron source [73]. Such studies have not been done 
yet.  
In mammals, it has been proposed that heme uptake from the enterocytes 
occurs through a receptor-mediated endocytic pathway. A study done by Grasbeck et 
al in pigs, showed the existence of a heme-binding protein on the microvilli of the 
upper small intestine [74]. Evidence for such an intestinal receptor has been reported 
in humans [75]. It has also been shown that this high affinity binding is lost when a 
trypsin digestion is performed, indicating the existence of a receptor for heme [76]. 
Electron microscopy studies have been performed after administration of heme or 
hemoglobin into the duodenum from rats or dogs. These studies reported the presence 
of heme on the microvilli and then accumulation of heme in vesicles that were 
identified as secondary lysosomes [12]. Heme was absent from these vesicles 2-3 
hours after the initial dose and heme was not observed in the basal region of the cells.  
These results provided strong evidence that heme uptake occurs via endocytosis, but 
the heme-binding receptor has yet to be identified [12]. Although results from this 
study also suggested that iron released from heme is transported out of vesicles, no 
such transport mechanism has been identified.  
Shayegi et al identified SLC46A1 as a heme carrier protein and named it 
HCP-1[77]. Hcp-1 was isolated from mouse duodenum using a suppression 
subtractive hybridization screen using hypotransferrinaemic mice [78]. Hcp-1 
encodes a protein of ~ 50 kDa that localized to the plasma membrane. Functional 
studies in Xenopus oocytes expressing Hcp-1, revealed a 2-3 fold increase in heme 
uptake with an apparent Km of 125 μM. Uptake of radiolabeled heme from duodenal 
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tissue was inhibited upon incubation with HCP-1 antibodies. However, recent studies 
have shown that SLC46A1 is in fact a folate/proton symporter and was renamed as 
the Proton Coupled Folate Transporter (PCFT/HCP-1) [79]. RNA interference assays 
of PCFT/ HCP-1 in CaCo-2 cells reduced pH-dependent folate uptake by 60-80%. 
Folate transport by this protein was at least an order of magnitude higher than that 
observed for heme with a Km of ~1.3 at pH 5.5, suggesting that folate might be the 
physiological ligand for HCP-1. Interestingly, human patients with hereditary folate 
malabsorption carry a missense mutation in PCFT/HCP-1 that leads to the formation 
of a non-functional protein. It is currently unclear whether PCFT/HCP-1 is a low 
affinity heme transporter. 
Although the heme biosynthesis pathway and its intermediates are well 
characterized, the export of ALA out and the import of coproporphyrin III into the 
mitochondria for heme biosynthesis are unknown [80]. Recently published reports 
have identified potential porphyrin transporters. A mammalian ABC transporter 
located on the outer mitochondrial membrane, ABCB6 was shown to interact with 
heme and porphyrins [81]. The authors of this study demonstrated that ABCB6 
transports coproporphyrin III (CPIII) from the cytoplasm into the mitochondria. The 
authors extrapolated their findings to suggest that ABCB6 transports 
coproporphyrinogen III (CPgen III), an intermediate in the heme biosynthetic 
pathway, from the cytoplasm into the mitochondria [81]. A major setback of this 
study is that the authors used a non-physiological substrate CPIII, which is a planar 
porphyrin, rather than the non-planar CPgen III. A parallel study by Kabe et al 
showed that the inner mitochondrial protein, oxoglutarate carrier (OGC) facilitates 
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uptake of 2-oxoglutarate into the mitochondria. In this study, the authors used two 
fluorescent non-physiological porphyrin derivatives PdTCPP and PdTAPP. These 
molecules accumulated in the mitochondria, and, various techniques were used to 
show that these porphyrin derivatives bind OGC [82]. Transport of 2-oxoglutarate 
was inhibited by different porphyrin derivatives including protoporphyrin IX, 
coproporphyrin III and hemin [82]. A major caveat in this study is that the work was 
performed using synthetic porphyrin derivatives, which do not resemble CPgen III 
and their physiological and biochemical properties have not been characterized.  
Two ABC transporters have been implicated in mediating transport of 
components required for heme biosynthesis and hematopoiesis, although the ligands 
of these transporters are unknown. To identify novel GATA-1 (a transcription factor 
essential for normal erythropoiesis) regulated genes, Shirihai et al. conducted a 
subtractive analysis in G1E cells (an erythroid line from GATA-1 lacking embryonic 
stem cells) and identified ABC-me (ABC-mitochondrial erythroid) [83]. They 
showed that this protein localizes to the mitochondrial inner membrane and is induced 
during erythroid maturation. They also found that overexpression of ABC-me induces 
hemoglobin synthesis in erythroleukemia cells. Because of the expression pattern, 
mitochondrial localization and overexpression effects of ABC-me, the authors 
suggest that ABC-me may mediate the transport of one or more intermediates of the 
heme biosynthesis [83].  
Pondarre et al. have shown that the mitochondrial ATP-binding cassette 
transporter Abcb7 was essential for hematopoiesis and that partial loss of function 
mutations in Abcb7 resulted in X-linked sideroblastic anemia with ataxia [84]. The 
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authors showed by chimera analysis in mice, that the zinc protoporphyrin/heme ratio 
in erythrocytes increased in proportion to the contribution of Abcb7E433K mutant cells 
(a hematologically severe form of mutation in humans) suggesting that loss of 
function of Abcb7 alters the availability of reduced iron to synthesize heme [84]. 
Two heme exporters have been reported in erythroid cells. The feline 
leukemia virus receptor was initially identified as a cell surface protein for feline 
leukemia virus subgroup C [85]. Infection of cats with this virus resulted in aplastic 
anemia, a type of anemia in which erythroid progenitor cells failed to mature from 
burst-forming units to the colony-forming units-erythroid cells. This virus-induced 
anemia has been mapped to a region of the gene encoding the surface envelope 
glycoprotein region 1. The surface envelope glycoprotein region 1 binds to the host 
receptor, feline leukemia virus subgroup C receptor or FLVCR [86]. FLVCR, a 
60kDa protein, is a member of the major facilitator superfamily. It shares amino acid 
sequence homology to at least five C. elegans proteins of unknown function. FLVCR 
is expressed in different hematopoietic cells and showed weak expression in the fetal 
liver, pancreas and kidney [85]. Quigley et al have shown that FLVCR can mediate 
efflux of zinc mesoporphyrin in rat renal epithelial and hematopoietic K562 cells. 
They have also shown that heme efflux mediated by FLVCR is important for 
erythroid differentiation [87]. Keel et al recently reported that FLVCR-null mice fail 
to undergo erythropoiesis and die at midgestation [88]. These mice also exhibit 
cranio-facial and limb deformities reminiscent of patients with Diamond-Blackfan 
anemia, a severe but rare congenital erythroid anemia that presents in infancy. By 
using HO-1 and ferritin as reporters for heme and iron status in macrophages, the 
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authors showed that FLVCR exported heme when macrophages phagocytosed 
senescent red blood cells. These observations confirm the results from a previous 
study performed by Knuston et al, which demonstrated that not all heme is broken 
down in the macrophage to release iron [89].  
A second heme exporter, ABCG2 was identified recently [90]. ABCG2 
belongs to ATP-binding cassette (ABC) transporter family and was initially identified 
as a protein that confers drug resistance in breast cancer cells. The role of ABCG2 in 
heme transport was discovered accidentally when ABCG2-null mice fed a modified 
diet developed skin photosensitivity [91]. This was due to the accumulation of a 
degradation product of chlorophyll, pheophorbide a, which is structurally similar to 
protoporphyrin IX. This suggested a role for ABCG2 as an exporter of 
protoporphyrin compounds. Expression of ABCG2 is regulated by HIF1, and it has 
been shown that ABCG2 transported porphyrins under hypoxic conditions [92]. The 
problem with the conclusions of this study is that the mice lacking the putative heme 
exporter ABCG2 did not have any phenotypes associated with defects in heme 
dependent pathways other than mild photosensitivity.  
 
C. elegans as a model organism 
 
A major experimental setback in identifying molecules and pathways involved 
in heme homeostasis has been the inability to dissociate tightly controlled heme 
biosynthesis and degradation from intracellular trafficking events. The need for 
identifying better tools and tractable model systems to study heme homeostasis led 
our research group to identify Caenorhabiditis elegans, a free-living nematode, as a 
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natural heme auxotroph. This round worm lacks all eight genes required to synthesize 
heme and acquires heme from its diet to sustain growth and development [93]. 
Importantly, the phylogenetically related parasitic nematodes were also found to be 
heme auxotrophs [93]. 
Helminthic infections are a huge burden to both public health and agriculture. 
More than two billion people are afflicted by helminthiasis, and agricultural losses 
due to plant-parasitic nematodes are estimated to be approximately eighty billion 
dollars annually [94, 95]. Drug resistance is rampant, and there is a need to find new 
drug targets to eliminate these infectious agents [96, 97]. Genomic analysis of heme 
biosynthetic enzymes has revealed that C. elegans lacks orthologs for these enzymes. 
Heme biosynthetic enzyme activity measurements confirmed that C. elegans lack the 
ability to make heme [93]. It has been shown that other free-living nematodes such as 
Panagrellus redivivus, Oscheius myriophila and Paragordius varius and parasitic 
nematodes such as Strongyloides stercoralis, Ancylostoma caninum, Haemonchus 
contortus, Trichuris suis and Ascaris suum also lack the enzymes that are required for 
heme biosynthesis [93]. Analysis of the genomes for these nematodes, however 
indicate that they encode abundant hemoproteins suggesting the possibility that they 
must acquire heme from their environment. Using a liquid axenic growth medium, it 
was demonstrated that C. elegans have a biphasic requirement for heme and therefore 
rely on exogenous heme for metabolic processes. This suggests that worms might 
have evolved specific mechanisms to absorb heme from their diet and transport heme 
to cellular compartments for incorporation into hemoproteins. It is possible that 
worms also have a heme storage system to store any excess heme and an intercellular 
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heme transport system to mobilize heme from intestinal cells, the site of absorption, 
to other cell types.  
Reports published have suggested a role for heme in the pathogenicity of 
different parasitic worms. Hookworm infections due to Ancylostoma ceylanicum is 
prevalent in developing countries and is associated with iron deficiency anemia. A 
recent study demonstrated the importance of host iron status as a key mediator of 
hookworm pathogenicity [98]. Hamsters fed a normal diet or a diet with severe iron 
restriction, were infected with hookworms. Animals fed a diet with reduced iron had 
a significant reduction in the intestinal load of worms. This observation suggested 
that hookworms rely on host iron for their growth and development and that treatment 
of hookworm infection with anthelminthic drugs in combination with iron 
supplements might exacerbate the severity of infection. Since hookworms, like C. 
elegans, also lack the ability to make heme, another plausible explanation given by 
the authors was that animals fed a low-iron diet have reduced worm burden due to 
inadequate amounts of heme for hookworm metabolism [93, 98].  
 Brugia malayi, a filarial nematode, is the causative agent of lymphatic 
filariasis that is endemic in Asia.  Analysis of the genome sequence of Brugia malayi 
revealed the absence of the heme biosynthesis enzymes in these parasites [99]. 
Therefore, it is highly likely that these parasites obtain heme from the host or from 
Wolbachia, an intracellular endosymbiotic bacterium. Wolbachia has all but one of 
the heme biosynthetic enzymes and is probably an important heme source for B. 
malayi. Antibiotics that eliminate the endosymbiont have inhibitory effects on the 
development and fertility of the parasitic nematode and have been used to treated 
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patients with filariasis. Since heme is important for the growth and development of 
the nematode another potential drug target is the heme uptake pathway in B. malayi 
or the heme biosynthesis pathway of Wolbachia [100].   
Our observations that C. elegans lacks the ability to make heme and acquire 
heme exogenously from their diet permits its use in the interrogation of the role of 
heme in human nutrition and cell biological aspects of heme homeostasis. In 
principle, intestinal heme absorption in C. elegans may be similar to dietary heme 
uptake by the human intestine. Furthermore, the absence of intracellular heme 
synthesis in C. elegans provides a “clean” genetic background to study organismal 
heme trafficking pathways. C. elegans has been used as a model organism for over 
four decades [101]. The developmental fate map for every cell has been determined. 
The genome has been fully sequenced and more than 70% of human genes are 
conserved in C. elegans [102, 103]. These animals are genetically tractable, optically 
transparent and greatly amenable for genetic screens and cell biological studies. 
Taken together, C. elegans, a natural heme auxotroph, serves as a unique animal 





Chapter 2 Materials and Methods 
Worm cultures 
 
When control over heme was required worms were cultured with shaking at 20°C in 
mCeHR-2 medium supplemented with either 10 or 20 μM hemin (Frontier Scientific) 
[104]. When solid media was required, worms were grown on nematode growth 
medium (NGM) agar plates (3 g/L NaCl, 2.5 g/L peptone, 30 g/L agar, 5 mg/L 
cholesterol, 0.1 M CaCl2, 0.1 M MgSO4 and 25 mM KH2PO4) spotted with OP50 
bacteria. For RNA-mediated interference assays, NGM plates were made as described 
above but also contained 50 μg/mL carbenicillin, 12 μg/mL tetracycline and 2 mM 
IPTG (to induce the synthesis of double stranded RNA). RNAi plates were spotted 
with HT115 (DE3) bacteria (an E. coli strain that is deficient for RNase III that 
normally degrades dsRNAs and takes advantage of an IPTG-inducible T7 RNA 
polymerase gene contained within a stable insertion of lambda prophage DE3) [105]. 
Synchronization of worms 
 
Worms in liquid mCeHR-2 medium were harvested by centrifugation at 800 X g for 5 
min [104]. The medium was aspirated and 0.1 M sodium chloride was added. The 
worms were allowed to settle on ice for 5 min. The supernatant was aspirated and the 
adult worms that settled at the bottom of the tube were bleached using a solution of 
1.1 % sodium hypochlorite (Clorox bleach) and 0.55 M sodium hydroxide to harvest 
eggs [104]. The eggs were washed twice (800 x g, 45 sec) with sterile water and were 
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allowed to hatch overnight at 20°C in M9 buffer (86 mM NaCl, 42 mM Na2HPO4, 22 
mM KH2PO4 and 1 mM MgSO4). 
Preparation of hemin chloride 
 
10 mM hemin chloride was prepared by dissolving 0.1301g of hemin chloride in 20 
mL of 0.3 N NH4OH. The pH was adjusted to 8.0 using HCl, and the volume was 
brought up to 20 mL with 0.3 N NH4OH, pH 8.0. The solution was filtered using a 
0.22 μm filter (Millipore) and frozen for up to a week at -20°C. Zinc mesoporphyrin 
(ZnMP), gallium protoporphyrin IX (GaPPIX) and protoporphyrin IX were prepared 
as described above except these solutions were not filtered. All porphyrin compounds 
were obtained from Frontier Scientific. 
Hemin dose response 
 
Synchronized L1 larvae were obtained by bleaching P0 worms grown at 20 μM 
hemin. 100 L1 larvae were placed in 24-well plates containing mCeHR-2 medium 
with different concentrations of heme. The plates were covered with foil and worms 
were grown at 20°C with continuous shaking. Worm growth was monitored every 
day. The total number of worms from two replicate samples was counted on day nine. 
Averages of the total number of worms from the two replicate samples were used to 






RNA isolation and microarray analysis 
 
Equal numbers (3000 worms/mL) of L1 larvae (F1), which were obtained 
from P0 worms grown at 20 μM hemin chloride, were inoculated in mCeHR-2 
medium with 4, 20 or 500 μM hemin chloride and grown at 20°C with continuous 
shaking. They were grown till they were gravid adults that were bleached to obtain F2 
larvae. Synchronized F2 larvae were obtained by hatching the eggs obtained from F1 
adults in M9 buffer containing 4, 20 or 500 μM hemin.  Equal numbers (3000 
worms/mL) of L1 larvae (F2) were inoculated in mCeHR-2 medium supplemented 
with 4, 20 or 500 μM hemin.  They were grown with continuous shaking at 20°C. The 
worms were harvested at the late L4 stage, flash frozen in liquid nitrogen, and stored 
at -80°C.  Frozen worm pellets were ground into a fine powder using a mortar and 
pestle, and total RNA was extracted using Trizol (Invitrogen).  RNA thus obtained 
was subjected to RNase-free DNase treatment for 1 h at 37°C and purified using the 
RNeasy kit (Qiagen). Total RNA from three biological replicates was hybridized to 
Affymetrix C. elegans whole genome arrays.  The RNA samples were processed by 
the DNA microarray facility at the National Institute of Diabetes and Digestive and 
Kidney Diseases, NIH. The resulting data were normalized for 20-probe set data files 
and analyzed using MAS 5.0 (Affymetrix).  Data from worms grown in mCeHR-2 
medium with 4 and 500 μM hemin were compared to data from worms grown in 20 
μM hemin.  Microarray data were verified with the Robust Multichip Average 
Method (RMA, R package) [106].  Quantile normalization and background 
corrections were performed using PM (perfect match) probe intensities.  A total of 
288 heme-responsive genes were obtained using both MAS 5.0 and RMA (fold 
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change cut-off ≥ 1.6) analyses. Amino acid sequences for each of these 288 genes 
were obtained from Wormbase and further analyzed for topology (TMHMM 2.0, 
SOSUI), motifs (ELM, BLOCKS, Pfam), and pathway classification (KEGG).  
Putative human orthologs were identified by BLAST searches (E-value ≤ 10-4) of the 
human genome databases for the 288 candidate genes.  Multiple sequence alignment 
was performed using ClustalW (v. 1.83)  
cDNA synthesis and  quantitative real-time PCR  
 
First strand cDNA was synthesized using 2 μg of total RNA using Superscript II First 
Strand cDNA synthesis kit (Invitrogen). Primers spanning at least one intron for 
quantitative real-time PCR (qRT-PCR) were designed using Primer Express (Applied 
Biosystems) and Beacon designer 4 (Premier Biosoft) programs. PCR was performed 
using the iCycler iQ Real-time PCR Detection System (BioRad) with 0.12 U/µl Taq 
DNA polymerase, 40 nM fluorescein (Invitrogen), and SYBR Green I Nucleic Acid 
Gel Stain (Invitrogen) diluted 1:10 [107].  The PCR amplification was run for 40 
cycles. The PCR products were between 150 and 200 bp in length. Quality of the 
PCR products was determined by dissociation curve analysis and gel electrophoresis.  
Each experiment was performed in triplicate.  Average CT values were used for 2-∆∆Ct 
calculations of relative fold changes in gene expression [108].   
RNA blotting 
 
For RNA blot analysis, 10 μg of total RNA from N2 worms grown at 4, 20 or 500 
μM hemin chloride was resolved on a 1.5 % formaldehyde agarose gel, transferred to 
a nylon membrane (Zeta Probe, BioRad) and probed with  32P-α-dCTP (Amersham 
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Biosciences) labeled cDNA that was generated using the random priming kit 
(Stratagene).  The probes were hybridized to the membrane for 16 h in ULTRAHyb 
buffer (Ambion), washed, and analyzed after 48 h with a PhosphorImager (Molecular 
Dynamics).  
Generation of the hrg-1::gfp heme-sensor strain 
 
The putative promoter (~3 kb upstream of ATG start codon) of C. elegans hrg-1 was 
cloned into the PstI - ApaI sites of vector pPD95.67 (Fire vector kit) that contained 
GFP preceded by a nuclear localization signal and followed by unc-54 3’UTR, to 
create a hrg-1::gfp transcriptional fusion. Transgenic lines were generated by 
microinjection of 50 ng/μl of the hrg-1::gfp plasmid into wild-type N2 worms along 
with pRF4 plasmid (rol-6) for positive selection of transformants [109]. The 
transformant with 25 % trasmittance of GFP expression was chosen for integration. 
The integrated transgenic strain (IQ6011) was generated using gamma radiation 
(2500 rads/5 min). After gamma irradiation, worms were allowed to recover. About 
100 F1 progeny were picked singly onto NGM plates spotted with OP50 bacteria. 
After the F1 worms laid progeny, about 5 F2 worms from each of the 100 plates were 
picked singly and analyzed for the Rol phenotype. Transgenic lines with 100% 





RNA-mediated interference assays 
 
C. elegans hrg-1 and hrg-4 open reading frames were cloned into the PstI- HindIII 
sites of the L4440 RNAi feeding vector and transformed into the E. coli HT115(DE3) 
strain. RNAi feeding bacteria were grown in LB broth supplemented with either 5 or 
25 µM hemin or no added hemin (0 µM) for 5.5 h. NGM agar plates for RNAi were 
spotted with the RNAi feeding bacteria and the bacteria were allowed to induce for 24 
h at room temperature. Equal numbers of IQ6011 synchronized F1 L1 larvae, obtained 
by bleaching P0 worms grown in mCeHR-2 medium plus 10 μM hemin, were placed 
on the NGM plates spotted with the RNAi feeding bacteria.  After feeding on RNAi 
bacteria for 96 h, worms were analyzed with a Leica MZF16A fluorescence 
stereoscope. The fluorescence intensity measurements were quantified with 
SimplePCI v 6.2 (Hamamatsu). P values for statistical significance were calculated 
by using a one-way ANOVA with Student–Newman–Keuls multiple comparison test 
by using INSTAT version 3.06 (GraphPad, San Diego). 
ZnMP uptake assays 
 
The NGM plates for RNAi were prepared and spotted with RNAi feeding bacteria as 
described previously, except the bacteria were grown in LB broth without any added 
heme. For analysis of ZnMP (Frontier Scientific) uptake, equal numbers of IQ6011 
synchronized F1 L1 larvae, obtained by bleaching P0 worms grown in mCeHR-2 plus 
1.5 µM hemin, were exposed to the RNAi bacteria on NGM plates for 60 h. The 
worms were then washed with M9 buffer and transferred to mCeHR-2 medium 
containing 1.5 µM hemin and 10 µM ZnMP. Worms were grown at 20°C with 
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continuous shaking for 16 h. To measure ZnMP fluorescence intensity in the worms, 
images were taken using a Leica DMIRE2 epifluorescence/DIC microscope fitted 
with a Rhodamine filter and a CCD camera. Image intensities were quantified with 
SimplePCI. For the deletion strains, ZnMP uptake assays were performed as 
described above except regular NGM plates spotted with OP50 bacteria were used. P 
values were calculated as described previously. 
GaPPIX toxicity assays 
 
Twenty synchronized L1 larvae, obtained by bleaching P0 worms grown in mCeHR-2 
medium with 1.5 μM hemin, were placed on NGM plates spotted with RNAi bacteria 
grown in LB broth without any added heme. After 60 h, the worms were then 
transferred to NGM plates containing 1 μM GaPPIX and spotted with RNAi bacteria 
to sustain knock-down of the hrgs. After 24 h of egg-laying, the gravid mothers were 
picked and burned to prevent additional eggs from being laid. On day 5, the total 
number of surviving larvae and viable eggs that hatched was counted.  
 For GaPPIX toxicity measurements in the ∆hrg-1 and ∆hrg-4 deletion strains, 
ten L4 larvae from each strain were transferred to NGM agar plates spotted with 
OP50 bacteria. After allowing the gravids to lay eggs for 36 h, the number of 







Biolistic transformation of C. elegans 
 
Large numbers of unc-119 (ed3) worms were grown at 20°C with continuous shaking 
in 90 mL of mCeHR-2 medium in T175 cm2 flasks containing mCeHR-2 medium 
with 20 μM hemin. For biolistics transformation, the worms were transferred to 50 
mL conical centrifuge tubes and spun at 800 X g for 2 min. Worms were resuspended 
in M9 buffer, and the adult worms in the 50 mL tubes were allowed to settle for 15 
min on ice. The supernatant was aspirated, and the washing process was repeated 
twice. The worms were then evenly distributed to form a confluent layer on a chilled, 
10 cm, unseeded NGM agar plate.  
Gold particles were prepared by weighing 30 mg of the particles into a silicon-treated 
1.5 mL microcentrifuge tube. The particles were then soaked in 70% ethanol for 15 
min, washed three times with sterile water and resuspended in 0.5 mL of 50% 
glycerol. For each transformation, 5 μg of unc-119 rescue plasmid was mixed with 8 
μg of plasmid containing either Cehrg-1 or hrg-4 constructs, and the total volume 
was brought to 50 μL with sterile water. The DNA mix was then mixed with 100 μL 
of the gold particles. To this mixture, 150 μL of 2.5 M CaCl2 and 60 μL of 0.1 mM 
spermidine (Sigma) were added. The mixture was briefly spun at 6000 X g, and the 
supernatant was removed. The pellet was resuspended in 300 μL 70% ethanol and 
spun briefly. After removing the supernatant, 170 μL of 100% ethanol was added to 
the pellet and vortexed for 10 min. 20 μL of DNA-coated gold particles were spread 
onto each of the seven macrocarriers (BioRad) and allowed to dry.  
 The transformation was carried out using the PDS-1000/He particle delivery 
system with the Hepta adaptor (BioRad), as per manufacturer’s instructions [110]. 
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After transformation, worms were allowed to recover for 30 min and were transferred 
from the NGM plate to a 50 mL tube using 10 mL of M9 salt solution. Equal volume 
of worms (500 μL) in the M9 buffer were spread on to 20 NGM agar plates seeded 
with 500 μL of JM109 bacterial strain. Once the excess liquid had been absorbed by 
the plates, the plates were incubated at 25°C for two weeks. The plates were analyzed 
for wild-type animals using a Leica stereoscope. The wild-type transformants were 
picked out singly onto NGM plates spotted with OP50 bacteria and their progeny 
were examined for GFP or YFP expression. 
Worm lysis and GFP measurements 
 
IQ6011 and IQ6041 worm strains were grown at 20°C with continous shaking in 
mCeHR-2 medium supplemented with 2 μM hemin, 4 μM hemin, 20 μM hemin, 4 
μM hemin with 20 μM protoporphyrin IX, or 4 μM hemin with 1 mM iron chloride 
for two generations. Worms were harvested by centrifugation at 800 X g for 5 min 
and washed twice with M9 buffer. The final worm pellet was resuspended in M9 
buffer with protease inhibitor cocktail set III (Calbiochem) and lysed with FastPrep-
24 (MP Bio) in the presence of Lysing Matrix D beads for 60s at the 6.5 m/s setting. 
The worm lysates were centrifuged twice at 16,000 X g for 30 min to remove worm 
debris, and 250 mg of the total protein, as measured by the Bradford (BioRad) 
method, was used to quantify GFP fluorescence. Measurements were obtained at 20º 
C using an ISS PC1 spectrofluorometer with a 1mm slit-width at a fixed excitation of 
488 nm. Scanning emission spectra (500-600 nm) were obtained for each sample, and 




PCR analysis using Rapid amplification of cDNA ends 
 
The SmartTM RACE cDNA amplification kit (Clontech) was used to generate cDNA 
from total RNA isolated from N2 worms grown at 4 μM hemin for RACE PCR 
analysis. All primers have a Tm between 62ºC and 65ºC. PCR amplification of cDNA 
was done using Advantage® 2 PCR enzyme system (Clontech). PCR products were 
cloned into the pCRII vector using a TA cloning system (Invitrogen). At least 5 
different clones for the 5’ and 3’ ends of each gene (hrg-1 and hrg-4) were sequenced 
and analyzed. 
Cloning of C. elegans hrg-1, C. elegans hrg-4 and human HRG1 
 
C. elegans hrg-1 and hrg-4 cDNA was cloned by reverse transcription of total RNA 
isolated from worms grown at 4 μM hemin, and amplified by PCR using primers 
containing BamHI and XhoI linkers, either with or without the HA epitope tag.  
Primers designed to amplify worm open reading frames were based either on 
Wormbase predictions or 5’ and 3’ RACE experiments. Human HRG1 was amplified 
from the image clone (Open Biosystems) by PCR using primers containing BamHI 
and XhoI linkers, either with or without the HA epitope tag. The PCR products were 
ligated into plasmids pCDNA3.1 (+) Zeo (Invitrogen) and pEGFP-N1 (Clontech) for 
expression in mammalian cells.  
 For zebrafish experiments, we cloned the Cehrg-1 construct tagged with the 
HA epitope into pCS2 (+) plasmid. For Xenopus experiments, the Cehrg-1, Cehrg-4 






HEK 293 cells were routinely cultured in basal growth medium composed of DMEM 
(GIBCO/BRL) and 10 % bovine serum (Atlanta Biologicals) supplemented with 
penicillin / streptomycin / glutamine. The pCDNA3.1 (+) Zeo and pEGFP-N1 
plasmids expressing CeHRG-1, hHRG1 or CeHRG-4 either with or without the HA 
tag were transiently transfected into cultured adherent monolayers of HEK 293 cells 
using Lipofectamine 2000 (Invitrogen). The pCS2 (+) and pT7TS plasmids 
expressing CeHRG-1, hHRG1 or CeHRG-4 with HA tag were also transiently 
transfected into HEK 293 cells. Cells were harvested 48 h post-transfection by cell 
lysis buffer (20 mM HEPES, pH 7.4, 0.5 % Triton X-100 and 150 mM NaCl) 
supplemented with protease inhibitor cocktail set III on ice for 15 min and cell lysates 
were clarified by centrifugation for 10 min at 10,000 X g at 4ºC.  The Bradford 
method was used to determine the protein concentration of the supernatant from all 
samples.  For immunoblotting, lysates were mixed with Laemmli Sample Buffer 
containing 100 mM DTT without heat denaturation, resolved by SDS-PAGE, and 
transferred to nitrocellulose membranes. The membranes were blocked for 1 h in 5 % 
blotto (5 % dry milk in 1X PBS/ 0.05 % Tween-80). After blocking, the membranes 
were incubated overnight at 4ºC in 5 % blotto containing rabbit polyclonal antibody 
against HA epitope at 1:5000 dilution (Sigma) or GFP at 1:2000 dilution (Qiagen). 
The membranes were washed three times at room temperature (10 min per wash) with 
1X PBS/ 0.05 % Tween-80 and incubated for 30 min at room temperature in 5 % 
blotto containing horseradish peroxidase-conjugated secondary antibody at 1:10,000 
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dilution (Pierce). The membranes were washed as previously described. The detection 
was done using the SuperSignal West Pico Chemiluminescence kit (Pierce). 
 Immunofluorescence assays 
 
For immunofluorescence experiments, HEK 293 cells grown on glass coverslips were 
transiently transfected with pEGFP-N1 plasmids either containing Cehrg-1, hHRG1 
or Cehrg-4 along with the organelle markers using FuGene 6 (Roche). 24 hours post-
transfection, the cells were fixed for 20 min at room temperature in freshly prepared 
4% paraformaldehyde and washed three times (5 min per wash) with 1X PBS. The 
fixed cells were incubated for 2 min in 1X PBS containing DAPI (1:50,000 dilution) 
and washed three times with 1X PBS. Coverslips were then mounted on microscope 
slides using ProLong Antifade (Molecular Probes). Confocal studies were performed 
using a laser scanning Zeiss LSM 510 confocal microscope with Argon (458 and 
488nm) and HeNe (543 and 633nm) lasers. A planApo 100X oil immersion objective 
lens was used. For labeling the plasma membrane, cells grown on coverslips were 
incubated with Alexa633-conjugated wheat germ agglutinin (Molecular Probes) for 5 
min at 37º C prior to fixation. Lysosomal (LAMP1::YFP) and endosomal (Rab7::CFP 
and Rab11::YFP) markers were generously given to us by Dr. Jennifer Lippincott-
Schwartz. 
`Heme / Iron depletion and MEL cell hemoglobinization studies  
 
 HEK293 cells were treated with heme-depleted medium (DMEM, 10 % heme-
depleted FBS, 1% PSG, 0.5 mM succinyl acetone) for 20 h.  Heme-depleted serum 
was generated by treatment with 10 mM ascorbic acid for about 7 h [111]. For iron 
 42 
 
chelation, 100 µM desferroxamine (Sigma) was added to the cells 6 h after addition 
of the heme-depleted medium. A 50 µM heme-replete medium was generated by 
mixing 10 mM hemin chloride and 1 mg/mL BSA stock solution with tissue culture 
medium and incubating overnight at 4°C.  For iron stock solution, 5 mM ferric citrate 
was mixed with 5 mM SIH (salicylaldehyde isonicotinoyl hydrazone) in a 1:2 ratio to 
generate Fe-SIH [112]. After 14 h incubation of the cells, the heme-depleted medium 
was replaced with medium containing DMEM, 10 % heme-depleted FBS, 1 % PSG, 
0.5 mM succinyl acetone (Sigma), and either 50 µM heme or 100 µM Fe-SIH. Cells 
were allowed to incubate in the fresh medium for an additional 3 h. After a single 
wash with PBS, total RNA was extracted using Trizol.  Extracted RNA samples were 
treated with TurboDNase (Ambion).  Total RNA (2 µg) from each sample was used 
for cDNA synthesis (iScript cDNA synthesis kit, BioRad).  qRT-PCR was performed 
using primers for hHMOX1, hTfR1 and hHRG1. Fold change was calculated using the 
2-ΔΔCt method. SIH was a generous gift from Dr. Prem Ponka. 
 Mouse erythroleukemia cells (DS19 clones) were cultured in DMEM, 10 % 
FBS, 1 % PSG, and 1% non-essential amino acids (Invitrogen). The cells were 
induced with 1.5 % DMSO (Sigma) to simulate erythroid maturation. After 4 days of 
induction, the cells were harvested. For the time-course study, cells were harvested 
every 12 h for the 72 h period after induction with DMSO. The cell pellets for RNA 
extraction were flash frozen in Trizol.  Total RNA was extracted from all samples and 
treated with TurboDNase. qRT-PCR was performed on cDNA synthesized (First 
strand cDNA synthesis kit, Invitrogen) using 2 µg of total RNA from each of the 
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samples. Quantitative analysis was performed using the 2-ΔΔCt method. Dr. Barry Paw 
generously gave us the MEL cells (DS19 clones). 
PCR genotyping worm deletion strains 
 
Single worms were lysed in a buffer containing 50 mM KCl, 10 mM Tris-HCl, 2.5 
mM MgCl2, 0.45% NP-40, 0.45% Tween-20, 0.01% gelatin and freshly prepared 
proteinase K at a final concentration of 1 mg/mL. The lysis was performed at -80°C 
for 2 hours, 65°C for 1 hour and 95°C for 30 min. PCR primers were designed to 
detect a 650 bp fragment of hrg-1 in the ∆hrg-1 strain (tm3199) and a 450 bp 
fragment of hrg-4 in the ∆hrg-4 strain (tm2994).  
Brood size assay and morphology assessment of the deletion strains 
 
Ten L4 larvae from each strain of worms were placed individually on NGM agar 
plates spotted with OP50 bacteria.  After allowing them to lay progeny for 2 days, the 
gravid worms were transferred to a new plate and the progeny from the previous plate 
were counted. This process was repeated twice and the total number of progeny was 
calculated.  
 For examining the morphological defects, worms were transferred to agar 
pads on microscope slide with ~ 20 μL of 10 mM levamisole. After placing a cover 
slip on the agar pad, the worms were analyzed using Leica DMIRE2 epifluorescence/ 
DIC microscope fitted with a 40X objective lens. Images were obtained using a CCD 
camera fitted to the Leica DMIRE2 microscope. The “percentage defects” was 
calculated by dividing the number of worms with defects by the total number of 
worms analyzed for each strain and multiplying by 100. 
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Chapter 3 Genome-wide analysis of genes involved in 
regulation of heme homeostasis 
Summary 
 
Heme is a prosthetic group of proteins that perform a wide variety of cellular 
functions [113]. Heme synthesis occurs via a multistep pathway with defined 
intermediates that are highly conserved among most eukaryotes [93]. Even though the 
pathways of heme biosynthesis and degradation have been well-characterized, the 
molecular mechanisms that are involved in intracellular heme trafficking in 
eukaryotes are unknown. One of the major setbacks in identifying the molecules and 
pathways that mediate heme homeostasis has been the inability to dissociate the 
tightly regulated processes of heme biosynthesis and degradation from intracellular 
trafficking events [80]. C. elegans lacks the ability to make heme, despite containing 
numerous hemoproteins associated with a variety of metabolic processes [93]. 
Furthermore, it has been demonstrated that worms utilize heme from their diet for 
incorporation in toto into hemoproteins [93]. Because hemes are hydrophobic 
macrocycles and free heme can cause cell injury due to its peroxidase activity, we 
rationalized that worms must regulate heme uptake. To understand the molecular 
mechanisms of heme homeostasis in eukaryotes, we conducted genome-wide 
microarray analysis using Affymetrix C. elegans genome arrays on RNA samples 
extracted from worms that were grown in mCeHR medium supplemented with 4, 20 
or 500 μM heme. Using two different methods (Microarray Suite software 5.0, MAS 
5.0 and Robust Multichip Average, RMA), a total of 288 heme-responsive genes 
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(hrgs) were identified. The 288 hrgs were either up or down regulated by at least 1.6 
fold at 4 and/or 500 μM heme compared to control samples at 20 μM hemin. There 
were 121 hrgs that had homologs in humans, suggesting that results from studies 
conducted in C. elegans can be useful to understand heme metabolism in humans. Of 
the 288 genes, 46 hrgs have been predicted to contain at least one transmembrane 
domain indicating that some of the hrgs could be membrane transporters involved in 
heme uptake or trafficking. The genome-wide microarray analysis provided the first 
comprehensive catalog of heme-responsive genes in any animal and whose products 




We have previously demonstrated that C. elegans lacks the highly conserved 
genes for heme biosynthesis [93]. To determine whether C. elegans requires heme for 
growth, worms were cultured in liquid axenic mCeHR medium in the presence of 
different amounts of heme. Worms responded in a biphasic manner to heme levels in 
the medium (Fig. 1). The optimal concentration for worm growth was 20 μM heme, 
and, at this concentration, the worms took about 3.5 days to reach the gravid stage 
from L1 larvae. The worms continued to grow and reproduce at concentrations 
ranging from 1.5 μM to 500 μM heme. At heme concentrations other than 20 μM, it 
took longer for the L1 larvae to reach the gravid adult stage and the brood size was 
smaller. Worms grown in the absence of exogenous heme arrested at the L4 larval 
stage, and the development of worms grown in ≥ 800 μM heme was arrested at the 
L2/L3 larval stages. This arrest was probably due to toxicity from excess heme.  
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 Our observations that worms can grow to the L4 larval stage in the absence of 
exogenous heme suggested that either there were trace amounts of heme in the 
growth medium or that maternal heme stored in the eggs during embryogenesis was 
sufficient to sustain larval development. We found that L1 larvae, when obtained 
from worms grown in CeHR medium containing 500 μM heme and transferred to 
CeHR medium lacking any exogenous heme, developed to the young adult stage. The 
progeny obtained from worms grown at 1.5 μM heme and transferred to CeHR 
medium lacking any exogenous heme were arrested at the L2/L3 larval stages (A.U.R 
and I.H. unpublished results). These results support our hypothesis that 
hermaphrodites stored heme in the eggs that was sufficient for early embryogenesis 
and post-embryonic development.  
To demonstrate that a heme uptake system exists in C. elegans, labeling 
experiments using a fluorescent heme analog, zinc mesoporphyrin IX (ZnMP), 
revealed that worms accumulate ZnMP and that the fluorescence of ZnMP can be 
competed by heme. Moreover,  worms grown at concentrations at or below 20 μM 
heme showed an uptake of ZnMP that was much more robust than that of worms that 
were grown at concentrations greater than 100 μM heme [93]. These results 
suggested that heme uptake was stimulated when worms were grown under limiting 
conditions of heme and heme uptake was down regulated when worms were grown at 
high heme concentrations. Taken together, these findings reveal that heme 
homeostasis in C. elegans is regulated in accordance with the metabolic requirements 
of the animal. Physiologically, this conclusion is reasonable because heme 
homeostasis necessitates maintaining a balance to ensure levels of heme are high 
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enough to perform all necessary biological functions but low enough to avoid toxicity 
due to excess heme. However, these data do not reveal whether heme regulation 
occurs at the transcriptional or post-transcriptional level. As a first step toward 
understanding heme homeostasis, we performed a genome-wide analysis using 
Affymetrix C. elegans whole genome arrays to identify genes that are regulated by 
heme at the transcriptional level.  
Worms were grown at 4, 20 or 500 μM heme in axenic CeHR medium. 
Worms grown at 20 μM heme were used as control samples because the heme dose 
response analysis showed that 20 μM heme was the optimal heme concentration, for 
growth and development (Fig. 1). Worms grown at 4 and 500 μM heme exhibited a 
16 h growth delay but were morphologically indistinguishable from worms grown at 
20 μM heme. In order to eliminate genes to eliminate the maternal load of heme as a 
variable, wild-type N2 worms were grown in mCeHR medium containing 4, 20 or 
500 μM heme for two generations (Fig. 2).  F2 worms were harvested at the late L4 
stage for RNA isolation. RNA was extracted, treated with RNase-free DNase and 
purified using Qiagen RNeasy column. Each experiment was performed three 




Figure 1. C. elegans requires heme for growth and reproduction. 
 
Biphasic response of C. elegans cultured in the presence of increasing amounts of 
heme (μM). One hundred larvae at the L1 stage were grown for 9 days in mCeHR 
medium in a 24-well plate with each well containing an increased concentration of 
heme (μM).  The total numbers of worms in each well were counted on day 9. Each 
data point represents the mean (± SD) from three separate experiments performed in 
triplicate. The red circle represents the hemin concentrations at which the worms had 







 The statistical analyses of the microarray data were initially performed using 
the Affymetrix MAS 5.0 Suite software. Of the 22,627 probe sets, 835 probe sets 
revealed changes at either 4 or 500 μM heme compared to the control data from 20 
μM heme. Using the cut-off of ≥ 1.6, we identified 288 genes from MAS 5.0 analysis. 
 The experiment was designed to minimize both the maternal effect of heme 
and the changes in genes that might be involved in heme regulation at the embryonic 
stage. In order to check if there were any germline genes that were transcriptionally 
regulated by heme, we compared results from our heme microarrays with the 
germline gene expression microarrays and identified 58 genes that were involved in 
worm developmental processes [114].  
The MAS 5.0 software uses the mismatch probe sets for background 
correction, and it has been reported to yield a significant number of false-positives 
[106]. We therefore also analyzed the microarray results using the Robust Multichip 
Average method (RMA from R package) which provides the users with the option of 
using only the perfect match probes for background correction [106, 115]. The 
disadvantage of the RMA method is that it compresses the fold change estimates by 
10-20% thereby, leading to a modest loss of accuracy and generation of false-
negatives [116]. Therefore, we used a lower threshold of ≥ 1.2 fold change in gene 
expression and identified a total of 82 genes. From these initial analyses using MAS 
5.0 (fold-change cut-off ≥ 1.6) and RMA (fold change cut-off ≥ 1.2), we obtained 370 
candidate genes. 
After eliminating the genes that were duplicated, increasing the fold change 
cut-off for RMA analysis to ≥ 1.6, and using the average fold change of the replicates, 
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there were 266 genes identified using MAS 5.0 and 22 additional genes using the 
RMA method. A total of 288 genes, including 8 previously identified germline genes, 
showed a ≥ 1.6-fold change in gene expression profiles at 4 or 500 μM heme 
compared to the control at 20 μM. A heat map for the 288 heme-responsive genes 
(hrgs) generated using Gene Spring version 5.0 revealed that the overall quality of the 
microarray data was consistent across the three biological replicates with the 
exception of one sample from worms grown at 4 μM heme which showed significant 
variability in comparison to the other two replicates (Fig. 3). We therefore excluded 
this particular sample from further analysis.  
The 288 heme-responsive genes (hrgs) were categorized based on whether the 
signal was up, down or unchanged in samples obtained from worms grown in 4 or 
500 μM heme as compared to the 20 μM reference samples. There were 80 genes that 
were upregulated at 4 μM heme and 75 genes that were upregulated at 500 μM heme 
(Table 1). We conducted quantitative real-time PCR (qRT-PCR) analysis on 30 genes 
to confirm the changes revealed by microarray analysis. 26 of the 30 genes were 
confirmed by qRT-PCR. A representative set of genes that have been confirmed are 
shown in Figure 4. Clustering analysis revealed that the majority of hrgs were 
clustered on chromosome V in the C. elegans genome (Fig. 5). Chromosome V has 
an increased number of hrgs that were upregulated at 4 μM heme.  
Using protein sequences obtained from Wormbase for these 288 hrgs, we 
performed BLAST and reciprocal BLAST searches to identify human homologs 
(Table 2) [117]. These searches revealed that there were 121 hrgs that showed 
sequence similarity between C. elegans and humans with an E-value cut-off ≥ 10-4. 
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Characterization of the hrgs common to both worms and humans might provide 
insights into the heme homeostasis pathways in mammals. 
We have previously demonstrated that parasitic nematodes also lack the 
ability to synthesize heme and rely on exogenous heme supply [93]. We therefore 
reasoned that genes, which are essential for heme homeostasis that is nematode-
specific, could be used as therapeutic drug targets for helminthic infections. 
Interestingly, analyses of the genome of Trypanosoma brucei suggested that the 
trypanosomes lack the genes encoding for heme biosynthesis enzymes [118]. With 
the help of our collaborator Dr. Najib El-Sayed (Maryland Pathogen Research 
Institute, University of Maryland), we were able to identify homologs in the parasites 
Schistosoma mansoni, Trypanosoma brucei, Trypanosoma cruzi and Leishmania 
major (Table 2). As shown in Figure 6a, of the 288 genes there were 12 heme 
auxotroph-specific hrgs, 37 hrgs that had homologs only in humans and 84 that were 
common to both. There were a total of 96 hrgs common between C. elegans and the 
parasites. This constitutes ~ 33% of the hrgs identified from the microarray analysis. 
Among the 109 genes upregulated at 4 μM heme, there were only 9 human-specific 
and 5 heme auxotroph-specific hrgs (Fig. 6b). Of the 104 genes that showed 
increased gene expression at 500 μM heme, 12 had human-specific homologs and 4 
hrgs were found in the parasite genomes (Fig. 6c). Altogether, these results reveal 
that hrgs, identified from our microarray experiment in C. elegans, have homologs in 




Figure 2. Schematic representation of the genome-wide analysis. 
 
Three independent sets of worms were grown at 4, 20 or 500 μM heme in mCeHR 
medium for two generations. Worms were harvested at the late L4 stage. RNA was 
isolated and hybridized to Affymetrix C. elegans whole genome array containing 
22,627 probe sets per chip. Affymetrix MAS 5.0 software and RMA were utilized to 
analyze the data. Data from worms grown at 4 and 500 μM heme were compared to 
control data from worms grown at 20μM heme.  The expression of 288 genes was 




Synchronize eggs overnight in M9 buffer @ 4,20 or 
500μ M heme
Synchronized N2 Worms in mCeHR-2 @ 20μ M heme
P0 worms
3000 L1/ml in 30ml mCeHR-2 with 4, 20 or 500μ M heme
F1 generation
3000 L1/ml in 30ml mCeHR-2 with 4, 20 or 500μ M heme 
F2 generation
Harvest late L4 stage worms for RNA
Hybridize cDNA to Affymetrix C. elegans genome 
array. 






Figure 3. Heat map for the heme microarrays. 
A heat map generated using Gene Spring version 5.0 for the 288 hrgs shows that the 
overall quality of the microarray data was good. Data from all nine chips are 
represented. The up and down arrows indicate upregulation or downregulation in 4 or 
500 μM heme when compared to 20 μM heme. The data from the first replicate 
sample from 4 μM heme, indicated with an asterisk, were inconsistent with the data 
from the other two replicates. Yellow represents no change in signal intensity, blue 
















Figure 4. Validation of microarray results by real-time PCR. 
Validation of microarray data by qRT-PCR on RNA from worms grown in mCeHR-2 
medium supplemented with 4, 20 or 500 μM heme. RNA from 20 μM heme was used 
as the reference sample. Data were compared to internal gpd-2 control and the fold 






Table 1. List of 288 genes identified from the microarray analysis. 
Description Gene name 4μM 500μM 4μM 500μM
C04H5.7 2.80 5.78 up up
C24F3.3 nas-12 3.05 1.83 up up
C32H11.10 dod-21 2.42 7.04 up up
C34H4.2 1.81 1.86 up up
F02D8.4 1.76 1.70 up up
F08F8.5 numr-1 7.66 8.23 up up
F21H7.1 gst-22 1.63 2.42 up up
F35C5.9 clec-66 1.93 2.08 up up
F49F1.6 3.32 10.71 up up
F54E2.1 2.22 1.70 up up
F58E6.7 71.25 1.66 up up
K01D12.14 cdr-5 72.08 3.79 up up
K02E2.4 ins-35 1.63 3.09 up up
K08B4.3 ugt-19 2.93 2.11 up up
K11H12.4 1.93 1.71 up up
M02F4.7 clec-265 2.16 2.86 up up
R10D12.9 1.64 2.48 up up
R186.1 2.81 1.70 up up
T05B4.3 phat-4 1.81 1.70 up up
T24A11.3 toh-1 1.80 1.63 up up
Y26D4A.10 1.75 2.20 up up
Y38E10A.5 clec-4 2.00 2.10 up up
Y40B10A.2 1.63 1.84 up up
Y40B10A.6 4.04 7.74 up up
Y51A2D.4 hmit-1.1 2.00 1.87 up up
Y54G2A.11 2.32 2.16 up up
Y75B8A.28 2.75 1.70 up up
ZC443.6 ugt-16 3.28 1.91 up up
C08F11.11 1.62 -2.02 up down
C15C8.3 16.57 -2.25 up down
C44B7.5 3.78 -2.14 up down
EEED8.3 2.00 -5.55 up down
F36H1.5 hrg-4 9.19 -1.81 up down
F57C2.4 2.94 -2.64 up down
F58E6.8 12.73 -2.40 up down
F58G6.3 2.75 -1.80 up down
F59D8.1 vit-3 4.35 -1.74 up down
K09F5.2 vit-1 1.65 -1.80 up down
W07B8.1 5.86 -1.91 up down
Y62H9A.6 2.83 -8.36 up down
ZK813.1 3.74 -3.37 up down
C01G6.3 3.62 -0.34 up
C04F6.1 1.74 -0.47 up
C05E7.2 1.74 1.35 up
C08B6.1 1.84 0.19 up
C10G8.4 4.20 1.51 up
C16C4.4 math-14 36.92 -1.33 up
C25A1.8 clec-87 2.15 0.35 up
C29E4.7 gsto-1 12.15 -1.32 up
C31C9.1 tag-10 4.59 -0.49 up
C33A12.6 ugt-21 2.87 1.14 up
C33H5.13 1.62 1.39 up
C42D4.3 1.93 1.39 up
C42D8.2 2.62 -0.71 up
C44B12.1 3.14 -1.03 up
C50H11.15 cyp-33C9 2.94 1.26 up
C54D10.1 cdr-2 1.66 1.53 up
C54F6.14 ftn-1 1.66 0.88 up
D1054.10 3.28 -1.44 up
F07C4.2 clec-45 3.51 0.48 up
F07C4.9 clec-46 2.93 0.53 up
F07F6.5 dct-5 1.68 1.35 up
F11G11.3 gst-6 1.88 1.59 up
F14F4.3 mrp-5 3.48 0.38 up
F15B9.6 4.78 1.49 up
F17E9.4 3.78 -0.79 up
F18A12.4 10.87 0.15 up
F26F12.1 1.72 -0.54 up
F32H5.1 3.14 0.36 up
F32H5.3 2.00 1.49 up
F35B3.4 2.14 1.48 up
F36A2.3 1.93 0.33 up
Description Gene name 4μM 500μM 4μM 500μM
F38A3.1 col-81 1.68 -0.48 up
F41F3.4 col-139 1.61 -0.25 up
F42G2.2 2.30 1.18 up
F44G3.2 1.80 -1.18 up
F47C10.2 btb-21 2.07 1.39 up
F48E3.4 1.80 -0.79 up
F52E1.1 pos-1 2.00 -0.44 up
F58E6.4 2.20 0.13 up
F59D6.3 2.22 -0.66 up
F59D8.2 vit-4 5.80 -1.34 up
H23N18.1 ugt-13 1.77 -0.17 up
K01D12.9 2.07 0.85 up
K02B9.1 meg-1 3.07 -1.10 up
K07H8.6 vit-6 4.45 -0.88 up
K10B2.2 2.84 0.25 up
K10D11.1 dod-17 1.68 0.62 up
M02H5.4 nhr-202 2.30 1.24 up
R02E12.6 hrg-1 16.04 0.33 up
R06C7.4 cpg-3 1.87 0.20 up
R193.2 2.82 -0.35 up
T02G5.11 1.96 0.33 up
T04G9.7 2.94 -0.63 up
T05A1.2 col-122 1.81 -0.74 up
T11F9.3 nas-20 1.87 -0.88 up
T18H9.1 grd-6 1.87 1.86 up
T21C9.13 2.94 -0.54 up
T21F4.1 1.80 1.43 up
T28C12.6 1.80 1.57 up
W02G9.4 1.68 0.33 up
W03G11.1 col-181 1.71 -0.51 up
Y37D8A.19 4.45 -0.68 up
Y54G11A.7 3.62 0.36 up
Y62H9A.4 4.66 0.66 up
Y73F8A.9 pqn-91 1.74 0.59 up
ZC373.2 4.01 -0.77 up
ZK1193.1 col-19 2.28 -0.22 up
ZK742.3 2.55 1.55 up
B0218.8 clec-52 -14.84 2.10 down up
C17F4.7 -1.91 1.82 down up
F08G5.6 -2.07 4.33 down up
F21F8.4 -2.65 1.70 down up
F55G11.4 -1.88 4.98 down up
T24B8.5 -3.22 5.59 down up
Y46C8AL.2 clec-174 -1.76 3.69 down up
Y46C8AL.5 clec-72 -1.69 2.04 down up
Y46D2A.2 -1.76 2.05 down up
ZK666.6 clec-60 -3.49 2.73 down up
C04G2.5 -1.70 -1.97 down down
C14C6.3 -2.32 -2.20 down down
E01G4.6 -2.62 -2.17 down down
E03A3.4 his-70 -2.39 -2.07 down down
F01G10.9 -1.78 -2.03 down down
F08H9.5 clec-227 -1.68 -2.10 down down
F09G2.3 -1.63 -4.62 down down
F10C2.7 -10.83 -4.26 down down
F15E11.12 -10.20 -4.21 down down
F15E11.15 -10.58 -3.85 down down
F22A3.6 ilys-5 -2.49 -1.87 down down
F22B5.4 -1.81 -2.79 down down
F28C6.5 -1.63 -1.64 down down
F44E5.4 -7.21 -4.14 down down
F44E5.5 -5.25 -4.16 down down
F55C10.4 -1.87 -2.31 down down
F56H6.5 gmd-2 -2.35 -4.15 down down
F57G8.7 -2.22 -2.70 down down
F58B3.2 lys-5 -2.07 -1.83 down down
K06H6.1 -2.67 -2.22 down down
K06H6.2 -4.67 -2.28 down down
T22B7.3 -2.39 -1.80 down down
W03F11.5 -1.68 -1.71 down down
W07A12.6 oac-54 -2.07 -2.42 down down
W07A12.7 rhy-1 -2.02 -2.37 down down
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Table 1, continued from previous page 
Description Gene name 4μM 500μM 4μM 500μM
Y105C5B.7 -3.14 -14.34 down down
Y43D4A.5 -2.77 -1.78 down down
Y71G12B.18 -12.25 -2.15 down down
D1086.3 -1.87 -1.41 down
F28H7.3 -1.68 0.52 down
F32A5.5 aqp-1 -1.74 -1.30 down
F46B6.8 -2.94 0.49 down
F47G9.3 cutl-18 -1.94 -1.29 down
F49E12.9 -1.87 1.37 down
F54D5.8 dnj-13 -1.68 -1.42 down
F54F3.3 -3.26 1.60 down
F58B3.3 lys-6 -2.00 -1.02 down
F59B10.5 -1.62 -1.39 down
H40L08.2 -2.23 0.38 down
K07E3.1 -1.68 -1.23 down
K10C2.3 -3.14 -1.49 down
M60.2 -2.02 0.36 down
R09B5.4 fpn-1.2 -1.88 -0.46 down
R13H4.3 -1.62 0.36 down
T07C4.4 spp-1 -1.80 -0.44 down
T08A9.8 spp-4 -1.80 -0.41 down
T10E9.8 -1.63 -1.49 down
T16G1.7 -2.07 -0.36 down
W03G1.7 -5.25 -0.10 down
W04E12.8 clec-50 -1.68 1.13 down
Y19D10B.7 -2.01 -0.31 down
Y37A1A.2 -2.02 -0.55 down
Y37D8A.4 -1.75 -1.52 down
Y46G5A.29 -1.75 -1.58 down
Y46H3A.2 hsp-16.41 -1.80 -0.08 down
Y46H3A.3 hsp-16.2 -1.74 -0.09 down
Y51H4A.5 -11.33 -0.74 down
Y54F10AM.6 -1.75 -0.64 down
Y5H2A.1 -2.02 -1.40 down
ZK377.1 wrt-6 -1.96 -1.59 down
ZK455.4 asm-2 -1.80 1.13 down
C03H5.1 clec-10 1.16 2.82 up
C13D9.9 ugt-7 1.49 2.40 up
C14C6.5 -1.23 3.12 up
C17H12.6 1.28 1.90 up
C25H3.10 1.15 2.99 up
C30G7.1 hil-1 1.23 1.87 up
C31H5.6 0.04 1.80 up
C32D5.6 1.23 1.75 up
C34H4.1 1.46 2.27 up
C45E5.4 1.32 1.65 up
C48B4.1 -1.20 1.66 up
E03H4.10 clec-17 1.16 2.73 up
F01D5.1 -1.11 2.56 up
F01D5.3 -1.52 2.10 up
F01G10.3 ech-9 -0.04 3.26 up
F08F3.3 rhr-1 1.12 1.98 up
F09C8.1 -1.47 2.38 up
F10A3.2 fbxa-88 -1.11 1.66 up
F20G2.1 1.29 2.01 up
F22A3.1 -0.22 1.67 up
F27C8.4 spp-18 -1.52 1.96 up
F27E5.1 1.28 1.67 up
F35C5.7 clec-64 0.43 3.37 up
F35C5.8 clec-65 1.32 1.87 up
F36G9.14 fbxa-99 1.00 1.71 up
F37B1.5 gst-16 1.37 1.77 up
F39E9.1 1.37 3.13 up
F44C8.1 cyp-33C4 0.28 2.28 up
F44G3.10 1.58 3.49 up
F46E10.11 1.19 1.62 up
F48G7.5 1.11 3.02 up
F48G7.8 0.16 3.07 up
F49F1.5 -1.28 2.87 up
F49H6.13 0.12 1.88 up
F49H6.3 1.19 2.10 up
F53A9.2 1.21 2.02 up
Description Gene name 4μM 500μM 4μM 500μM
F56A6.1 sago-2 -1.15 1.63 up
H20E11.1 1.12 1.68 up
K02G10.7 aqp-8 0.00 2.01 up
K08E7.9 pgp-1 0.00 2.15 up
M28.8 1.28 1.83 up
R09D1.8 0.44 2.53 up
R13A5.10 0.13 1.61 up
T01C3.4 -1.28 2.60 up
T05E12.6 1.23 1.96 up
T10B10.4 1.23 1.63 up
T10H4.12 cpr-3 1.28 2.17 up
T19C4.5 -0.08 1.77 up
T19C9.8 1.53 2.54 up
T21C9.8 ttr-23 1.47 2.17 up
W08E12.3 1.42 1.68 up
Y105C5B.15 -1.37 1.89 up
Y34F4.4 1.46 1.72 up
Y39D8C.1 abt-4 0.00 1.63 up
Y39G8B.7 -1.46 2.25 up
Y46C8AR.1 clec-76 1.53 1.75 up
Y47H9C.1 -1.07 2.73 up
Y48A6B.7 -1.11 1.72 up
Y48E1B.8 -0.04 1.87 up
Y50D4A.1 1.58 4.91 up
ZC443.5 ugt-18 1.21 2.37 up
ZK6.10 dod-19 1.15 2.44 up
B0286.3 -0.12 -1.97 down
B0393.5 -1.53 -1.67 down
C05C10.4 -1.28 -2.14 down
C06B3.7 1.21 -2.21 down
C07E3.10 -1.57 -1.69 down
C09D4.3 -1.24 -1.67 down
C24G7.2 -0.04 -1.70 down
C27D6.3 -0.21 -2.07 down
C33F10.1 0.12 -1.80 down
C34D4.3 1.37 -3.61 down
C50B6.7 1.23 -2.53 down
C55F2.1 -0.43 -2.17 down
F17C8.7 -0.30 -1.91 down
F26B1.1 1.35 -2.42 down
F26C11.1 -1.28 -10.56 down
F26H11.2 nurf-1 -1.17 -1.79 down
F28D1.5 thn-2 -1.28 -3.51 down
F32B6.4 -0.09 -1.66 down
F36A4.2 0.04 -2.75 down
F37B1.8 gst-19 1.39 -2.30 down
F38B6.4 -1.07 -2.03 down
F47C10.6 ugt-32 -1.46 -2.11 down
F47D12.7 -0.04 -3.49 down
F59C6.6 nlp-4 -1.52 -2.23 down
H25K10.1 -1.57 -1.74 down
K01A2.3 -1.11 -2.62 down
K01A2.4 -1.37 -11.35 down
K05F1.7 msp-63 1.49 -1.80 down
K07C6.4 cyp-35B1 -1.55 -6.77 down
K07E3.3 dao-3 -1.37 -1.73 down
K09C6.8 -0.40 -8.49 down
M02D8.4 -1.42 -1.75 down
T09F5.1 -1.52 -1.71 down
T09F5.9 clec-47 1.57 -8.01 down
Y11D7A.5 -1.53 -1.72 down
Y53F4B.32 gst-29 0.04 -1.97 down
Y59H11AM.3 1.57 -4.39 down
Y67A6A.2 -1.37 -1.75 down
Y71G12B.17 0.00 -1.73 down
Y71H2AM.16 -1.52 -2.15 down
ZK105.1 -0.16 -1.71 down
ZK520.5 cyn-2 -0.08 -4.81 down
ZK970.7 -0.08 -1.67 down
C45B2.5 gln-1 1.32 1.68 up
R03G8.3 1.39 1.79 up




To identify potential heme transporters among hrgs, we analyzed the 288 
proteins for putative transmembrane domains [58, 119-123]. Predictions using 
TMHMM 2.0 revealed that 41 of the 288 genes encoded for proteins that had at least 
one putative transmembrane domain (TMD) (Table 3) [124]. Interestingly, among 
these 41 genes were aquaglyceroporin-related proteins (aqp-1 and aqp-8 with 6 and 4 
TMDs respectively) that transport small molecules such as glycerol, urea and water; a 
cytochrome P450 family member cyp-33C9 (one TMD) predicted to bind heme and a 
permease (R02E12.6), with four transmembrane domains [125-127].  
Gene ontology analysis indicated that the hrgs identified from our microarray 
study were involved in a variety of processes such as embryonic development, 
electron transport, lipid metabolism and iron-sulfur cluster assembly (Table 4) [128]. 
There was no significant over representation of hrgs in any particular gene ontology 
term (biological process or molecular function) likely because heme is a cofactor for 
proteins that perform diverse biological functions. Of the 288 hrgs whose expression 
changed significantly in response to heme, only 63 (21%) have been assigned to any 
known biological processes.  
While GO analysis is useful for functional analysis of biological processes, 
current GO annotation for C. elegans is insufficient to make any functional 
predictions for the hrgs. The Kyoto Encyclopedia of Genes and Genomes (KEGG) is 
another tool that is frequently used to analyze complex microarray data and make 
functional predictions [129]. As shown in Table 5, analysis of the 288 hrgs revealed 
that only 10 hrgs (~3%) have been mapped to KEGG pathways. A majority of heme-
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responsive genes are novel and therefore have not been assigned to any known 
biological pathway.  
 Several genome-wide RNA-mediated interference (RNAi) 
experiments have been performed in C. elegans and the data from all these 
experiments are available on Wormbase [130-134]. We found that several RNAi 
phenotypes have been reported for 46 (`15%) of the 288 hrgs (Table 6). Of the 46 
hrgs with RNAi phenotypes, 13 were upregulated at 4 μM heme and 5 were down 
regulated at 4 μM heme. RNAi of most hrgs resulted in developmental defects such 
as embryonic lethality and sterility. This observation is physiologically significant 
because heme is essential for the reproduction of C. elegans, and, therefore, depletion 
of mRNA for genes involved in heme homeostasis will result in defects in animal 
growth and developmental [135]. These results are consistent with our studies which 
revealed that absence of any exogenous heme in the growth medium results in worm 




Figure 5. Chromosome clustering   
Clusters of heme-responsive genes whose transcript levels were altered at 4 μM (open 
bars) and/ or 500 μM heme (black bars). Genes that were upregulated are in red, and 







Category Heme Total* Orthologs § S. mansoni T. brucei T. cruzi L. major
4µM 500µM genes in humans
1 13 3 2 1 2 2
2 67 28 19 9 8 9
3 10 3 3 1 1 0
4 33 15 10 3 5 3
5 29 13 8 3 4 3
6 28 10 10 5 5 5
7 65 26 16 7 7 10
8 43 23 13 3 3 3
Total 288 121 81 32 35 35
Table 2. Heme-dependent changes in gene expression from C. elegans 
microarray. 
 
The 288 genes were categorized based on whether they were upregulated, down 
regulated or showed no change at 4 or 500 μM heme concentrations when compared 
to control data from 20 μM heme. C. elegans protein sequences for the 288 genes 
were used to perform BLAST and reciprocal BLAST searches to identify human 
homologs (E-value cut-off ≥ 10-4). Putative homologs were also identified in the 
parasitic helminth Schistosoma mansoni and protozoan parasites Trypanosoma 




Figure 6. Comparative analysis of the 288 hrgs across human and parasitic 
genomes 
Protein sequences for the hrgs obtained from Wormbase were used to search for 
homologs in the human genome and genomes of Schistosoma mansoni, Trypanosoma 
brucei, Tryoanosoma cruzi and Leishmania major. a) All 288 amino acid sequences 
were utilized to identify homologs in the indicated genomes. (b) and (c) Amino acid 
sequences for hrgs upregulated at either 4 or 500 μM heme were used to perform 






















Table 3. List of genes with predicted transmembrane domains 
 
Worm protein sequences obtained from Wormbase were analyzed using TMHMM 
2.0 to identify putative hydrophobic regions and transmembrane domains (TMDs). 
The 41 genes with putative TMDs have been sorted based on the number of TMDs. 
The fold changes at 4 and 500 mM heme have been indicated. Negative fold change 
implies down regulation. 
Description Gene name 4 μM fold change 500 μM fold change TMDs
Y39D8C.1 abt-4 0.00 1.63 15
F08F3.3 rhr-1 1.12 1.98 12
F10C2.7 -10.83 -4.26 12
F14F4.3 mrp-5 3.48 0.38 12
Y37A1A.2 -2.02 -0.55 12
K08E7.9 pgp-1 0.00 2.15 11
W07A12.7 rhy-1 -2.02 -2.37 11
Y51A2D.4 hmit-1.1 2.00 1.87 10
F09G2.3 -1.63 -4.62 9
R09B5.4 fpn-1.2 -1.88 -0.46 9
W07A12.6 oac-54 -2.07 -2.42 9
R10D12.9 1.64 2.48 8
F32A5.5 aqp-1 -1.74 -1.30 6
M28.8 1.28 1.83 5
F36H1.5 hrg-4 9.19 -1.81 4
F44G3.10 1.58 3.49 4
F49H6.13 0.12 1.88 4
F49H6.3 1.19 2.10 4
K02G10.7 aqp-8 0.00 2.01 4
K07E3.1 -1.68 -1.23 4
R02E12.6 hrg-1 16.04 0.33 4
T10E9.8 -1.63 -1.49 4
T21C9.13 2.94 -0.54 4
C13D9.9 ugt-7 1.49 2.40 3
F58G6.3 2.75 -1.80 3
K01A2.3 -1.11 -2.62 3
C24G7.2 -0.04 -1.70 2
C33F10.1 0.12 -1.80 2
F49E12.9 -1.87 1.37 2
F58E6.7 71.25 1.66 2
F58E6.8 12.73 -2.40 2
K01A2.4 -1.37 -11.35 2
K08B4.3 ugt-19 2.93 2.11 2
Y51H4A.5 -11.33 -0.74 2
B0393.5 -1.53 -1.67 1
C27D6.3 -0.21 -2.07 1
C50H11.15 cyp-33C9 2.94 1.26 1
C54D10.1 cdr-2 1.66 1.53 1
F22B5.4 -1.81 -2.79 1
R03G8.3 1.39 1.79 1
Y54G2A.11 2.32 2.16 1
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 Table 4. List of genes with known GO terms 
 
Biological processes and molecular functions associated with the 288 heme-
























* IEA, Inferred by Electronic Annotation; IMP, Inferred from Mutant Phenotype 
 
Description Molecular function Biological Process GO group*
B0286.3 Phosphoribosylamidoimidazole activity De novo IMP biosynthetic pathway IEA
B0393.5 Calcium ion binding Cell-matrix adhesion IEA
C01G6.3 Embryonic development IMP
C05C10.4 Acid phosphatase activity IEA
C09D4.3 Protein kinase activity Amino acid phosphorylation IEA
C15C8.3 Pepsin A activity Proteolysis IEA
C24G7.2 Sodium channel activity Sodium ion transport IEA
C27D6.3 Locomotory behaviour IMP
C29E4.7 Glutathione transferase activity Positive regulation of growth, embryonic development IEA, IMP
C31H5.6 Palmitoyl-CoA hydrolase activity Lipid metabolism IEA
C32D5.6 DNA repair IMP
C34D4.3 Structural molecule activity IEA
C44B12.1 Embryonic development IMP
C48B4.1 Acyl-CoA oxidase activity Electron transport IEA
C50B6.7 Catalytic activity Carbohydrate metabolism IEA
EEED8.3 Lipid binding Transport and embryonic development IEA, IMP
F01D5.3 Receptor activity IEA
F01G10.9 Reproduction IMP
F02D8.4 Carboxypeptidase A activity Proteolysis IEA
F08G5.6 Defense response IMP
F08H9.5 Sugar binding IEA
F09C8.1 Hydrolase activity Lipid metabolism IEA
F09G2.3 Inorganic phospohate transporter activity Phosphate transport IEA
F10C2.7 Transporter activity inorganic anion transporter activity IEA
F18A12.4 Metallopeptidase activity and zinc ion binding Proteolysis, neprilysin acitvity IEA
F20G2.1 Oxidoreductase activity Fatty acid biosynthesis IEA
F21F8.4 Aspartic-type endopeptidase Proteolysis IEA
F26C11.1 Acid phosphatase activity IEA
F28C6.5 Embryonic development IMP
F28H7.3 Triacylglycerol lipase activity Lipid metabolism IEA
F32H5.1 Cysteine-type peptidase activity Positive regulation of growth IEA, IMP
F36A2.3 Oxidoreductase activity Oviposition and locomotory behaviour IEA, IMP
F38B6.4 Catalytic activity Biosynthetic process IEA
F44E5.4 ATP binding, unfolded protein binding Iron-sulfur cluster assembly, Protein folding IEA
F44E5.5 ATP binding, unfolded protein binding Iron-sulfur cluster assembly, Protein folding IEA
F44G3.2 Kinase activity IEA
F46B6.8 Carboxylic ester hydrolase Lipid metabolism IEA
F46E10.11 Positive regulation of growth , larval development IMP
F47C10.2 Protein binding IEA
F47D12.7 Protein binding IEA
F48E3.4 Serine-type endopeptidase Proteolysis IEA
F48G7.5 Reproduction, gamete generation IMP
F49E12.9 Catalytic activity Metabolic process IEA
F53A9.2 Metallopeptidase activity and zinc ion binding Proteolysis IEA
F54F3.3 Carboxylic ester hydrolase Lipid metabolism IEA
F58G6.3 Copper ion binding activity Copper ion metabolism IEA
F58G6.7 Copper ion binding activity Copper ion metabolism IEA
F59D6.3 Pepsin A activity Proteolysis IEA
H25K10.1 Hydrolase activity IEA
K09C6.8 Protein kinase activity Serine/Threonine kinase activity IEA
K10C2.3 Protein kinase activity Serine/Threonine kinase activity IEA
M02F4.7 Sugar binding IEA
M28.8 Metabolic process IEA
M60.2 Defense response IMP
R09D1.8 Chitinase activity Chitin catabolic process IEA
R13A5.10 Zinc ion binding, hydrolase activity IEA
R13H4.3 Acid phosphatase activity IEA
R186.1 Embryonic development IEA
R193.2 Positive regulation of growth IMP
T01C3.4 Lipase activity Lipid catabolic process IEA
T02G5.11 RNA binding and zinc ion binding IEA
T04G9.7 Embryonic development IMP
T09F5.1 Galctosyl transferase Protein amino acid glycosylation IEA
T19C4.5 Iron, Oxygen and heme binding IEA
T21F4.1 Arginase activity Arginine catabolic process IEA
W07A12.6 Transferase activity Oviposition IMP
W07B8.1 Cysteine-type peptidase activity Proteolysis IEA
W08E12.3 Electron carrier activity Electron transport IEA
Y105C5B.15 Hydrolase activity IEA
Y105C5B.7 Hydrolase activity IEA
Y26D4A.11 Chromatin binding Chromatin assembly or disassembly IEA
Y37D8A.19 Larval development IMP
Y37D8A.4 Intracellular signaling cascade IEA
Y40B10A.2 O-methyl transferase activity IEA
Y40B10A.6 O-methyl transferase activity IEA
Y46C8AL.2 Sugar binding IEA
Y46D2A.2 Transcriptional elongation regulation activity Regulation of transcription IEA
Y46G5A.29 Calcium ion binding IEA
Y48A6B.7 Zinc binding, hydrolase activity IEA
Y51H4A.5 Triacylglycerol lipase activity Lipid metabolism IEA
Y54G11A.7 Binding Embryonic development IEA
Y71G12B.17 Transport IEA
Y71H2AM.16 Acid phosphatase activity IEA
ZK742.3 Oxidoreductase activity Electron transport IEA







Table 5. List of genes with KEGG descriptions 
Description Gene name KEGG pathway
C45B2.5 gln-1 Glutamate metabolism
F01G10.3 ech-9 Fatty acid metabolism
F14F4.3 mrp-5 Multidrug resistance protein
F32A5.5 aqp-1 Aquaglyceroporin related protein
F52E1.1 pos-1 Posterior segregation
F56H6.5 gmd-2 Fructose & mannose metabolism
F58B3.2 lys-5 Lysozyme
K07E3.3 dao-3 Lysozyme
T11F9.3 nas-20 Astacin protease
ZK455.4 asm-2 Sphingolipid metabolism
 72 
 





















* Embryonic lethal (Emb), maternal sterile (Ste), abnormal body morphology (Bmd), larval 
arrest (Lva), larval lethal (Lvl), protruding vulva (Pvl), slow growing (Gro), sterile progeny 
(Stp), abnormal life span (Age), abnormal egg laying  (Egl), uncoordinated movement (Unc), 
blisters (Bli), clear (Clr), aldicarb resistance (Ric), abnormal feeding behavior (Eat) 
 
Description Gene name RNAi phenotype*
C01G6.3 Ste,Emb
C04G2.5 increased fat content
C27D6.3 Unc
C29E4.7 gsto-1 Unc,Emb,Rup,Pvl,Egl,Gro,Chr segregation a
C30G7.1 hil-1 Egl,Spontaneous mutn rate increased, Unc
C32D5.6 Spontaneous mutn rate increased
C32H11.10 dod-21 Age


















F48G7.5 Ste, stp, Sck
F52E1.1 pos-1 Emb,intestinal development abnormal
F54E2.1 reduced brood size
F56A6.1 sago-2 Emb
F56H6.5 gmd-2 prl,Lvl,Unc,Lva,Bmd,Egl
F59D8.1 vit-3 Emb, Gro
F59D8.2 vit-4 Emb, Gro
H25K10.1 fat content reduced
K05F1.7 msp-63 sec:fat increased, Emb, fat reduced
K07C6.4 cyp-35B1 Age, fat content reduced
K07E3.3 dao-3 Age
K10D11.1 dod-17 Age














We postulated that specific molecules exist for the uptake and transport of 
heme within cells because free heme is hydrophobic and cytotoxic. A major 
impediment in the identification of heme uptake and transport pathways has been the 
inability to disassociate the tightly regulated processes of heme biosynthesis and 
degradation from heme transport. We have identified C. elegans as a unique animal 
model for interrogating the pathways involved in heme homeostasis because worms 
do not make heme but rather rely solely on exogenous heme for their growth and 
development (Fig. 1) [93]. Once worms absorb heme from the diet through the 
intestinal apical surface, we hypothesize that heme must be trafficked to different 
cellular compartments for incorporation into hemoproteins. It is also possible that in 
worms, there are specific molecules to transport heme from the intestine to other cell 
types. Unlike other organisms that make heme, C. elegans is unique, as it does not 
synthesize heme and thereby, for the first time, allows for external control of heme 
levels in an intact animal solely by dietary means.  
Using the Affymetrix C. elegans whole genome array, we performed a 
transcriptional profiling experiment to identify genes in worms that were regulated by 
heme at the transcriptional level. While the Affymetrix C. elegans whole genome 
array has been widely used since it was introduced in 2002, our study is the first of its 
kind as we have used the microarrays to study nutrient-gene interactions by growing 
worms in liquid culture [114, 136-139]. From our microarray analysis we identified 
288 genes that showed ≥ 1.6 fold change in gene expression at 4 or 500 μM. We 
confirmed the gene expression profiles for about 26 of the 288 genes. Among these 
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were aquaglyceroporin-like proteins (aqp-1 down regulated at 4 μM heme and aqp-8 
upregulated at 500 μM heme), cytochrome P450 family member (cyp-33C9) 
upregulated at low heme concentration and several genes of unknown function. 
Glutathione transferases (GST) are detoxifying enzymes that have been proposed to 
be heme-binding proteins in parasitic nematodes [140]. A recent proteomic analysis 
has identified GST-19 as highly heme-responsive. The authors have shown that it is 
produced under high heme levels and have proposed that GST-19 might be involved 
in processing heme compounds thereby indirectly influencing heme trafficking when 
there is an excess of intracellular heme concentrations [140]. Interestingly, there were 
three glutathione transferases (gst-22, gst-29 and gst-16) identified from our 
microarray analysis. It is possible that these genes might also play a role in 
maintaining intracellular heme levels. Gene ontology and KEGG pathway analysis 
showed that hrgs span across different biological process and there were only a few 
hrgs that are known heme enzymes or hemoproteins. This finding was surprising 
because it suggests that the heme homeostasis machinery is under transcriptional 
control by heme rather than the target proteins. The vast majority of hrgs are of 
unknown function, and, therefore, do not have any biological processes or pathways 
attributed to them. Furthermore, RNAi phenotypes reported for 46 of the 288 hrgs 
revealed that knockdown of the hrgs resulted in growth and developmental defects. 
Taken together, our findings are physiologically relevant because hemoproteins 
perform diverse functions ranging from miRNA processing (DGCR8) to gas sensing 
(hemoglobin) to regulation of gene expression (Bach1) and knockdown of genes 
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involved in maintaining heme homeostasis would result in severe phenotypes such as 
lethality [80, 141-145]. 
Although heme is an important cofactor of proteins that perform a wide 
variety of functions, the molecular mechanisms underlying the uptake and 
intracellular trafficking of heme in eukaryotes remain poorly understood. The results 
from our microarray analysis give us insights into heme homeostasis in eukaryotes at 
a global level. Observations made in C. elegans could also be extrapolated to heme 
homeostasis in humans as more than 40% of the worm hrgs have homologs in 
humans and may therefore have functionally conserved roles in various heme 
dependent pathways. Of these 288 hrgs, approximately 37 have homologs in humans 
but are absent in parasites suggesting a conserved role for some of these hrgs in 
regulating heme homeostasis in vertebrates. Presumably, of the 84 hrgs common to 
worms and humans there may be some that play an important role in heme uptake and 
trafficking in both worms and humans. 
Parasitic worm infections are a huge burden to public health since more than 
two billion people world-wide are afflicted by helminthic infections [146]. Annual 
crop losses due to plant-parasitic nematodes are estimated to be around eighty billion 
dollars [94]. There is an urgent need to find new drug targets to tackle helminthic 
infections because drug resistance is already prevalent in these parasites [96, 97]. We 
showed that parasitic nematodes lack the ability to make heme and rely on exogenous 
heme for their growth and development [93]. A recent study conducted by Held et al. 
has demonstrated that the infectivity of hookworms, which feed on blood in the host, 
was significantly lower in hamsters fed a low-iron diet [98]. This observation 
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revealed the importance of host heme and iron status in the survival of parasitic 
nematodes. Interestingly, protozoan parasites such as Trypanosomes, the causative 
agents of diseases such as sleeping sickness (Trypanosoma brucei), Chagas disease 
(Trypanosoma cruzi) and leishmaniasis (Leishmania major), also seem to lack the 
ability to make heme and therefore utilize exogenous heme [118, 147, 148]. 
Homology searches of the 288 heme-responsive genes identified from our microarray 
study in the genomes of the parasitic trematode S. mansoni and protozoans such as T. 
brucei, T. cruzi and L. major showed that of the 288 hrgs, 12 were specific to heme 
auxotrophs. This finding is significant because it indicates the existence of heme 
auxotroph-specific genes that may encode for proteins involved in heme uptake and 
transport pathways. These heme auxotroph-specific genes could potentially be used 
as novel drug targets against parasitic infections.  
Since membrane transporters have transmembrane domains, we analyzed the 
288 hrgs using TMHMM 2.0 and found that 41 of the 288 hrgs had at least one 
predicted transmembrane domain. It is possible that of the 41 hrgs, there might be 
some genes that encode proteins involved in heme transport. We have previously 
shown that gallium protoporphyrin IX (GaPPIX) is a highly toxic heme analog [93]. 
Thus depleting heme transport genes responsible for heme uptake may result in 
resistance to GaPPIX [93]. To test if any of these 41 hrgs were involved in heme 
uptake, we performed RNAi assays and looked for resistance against GaPPIX. Six of 
the 41 genes showed different levels of resistance against GaPPIX toxicity (A.U.R 
and I.H. unpublished results). Among these were pgp-1 (P- glycoprotein related 
protein, a member of ABC transporter superfamily), hmit-1.1 (proton-dependent myo-
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inositol transporter) and mrp-5 (multidrug resistance protein) [149]. Interestingly, 
there were ~ 247 genes that encoded for proteins without any predicted 
transmembrane domain. It has been demonstrated from iron and copper transport 
studies that soluble proteins such as chaperones (Atox1, a copper chaperone that 
delivers copper to Menkes ATPase) and storage proteins (Ferritin, an iron storage 
protein) play an important role in regulating the intracellular levels of toxic yet 
essential trace metals [150, 151].  
Although we have identified the heme-responsive genes in worms, it is 
important to characterize these genes in order to understand their role in regulating 
heme homeostasis. A powerful and a high-throughput approach to accomplish this 
goal, is to perform RNA-mediated interference assays. Using the hrg-1::gfp “heme-
sensor” strain generated in our laboratory, Dr. Severance in our research group 
conducted RNAi assays for all the hrgs identified from the microarrays. He found 53 
genes that caused aberrant regulation of GFP in the heme sensor strain. It is therefore 
possible that some of these genes might be involved in the heme homeostasis 
pathway. 
The results from the microarray analysis in C. elegans will help in providing 
molecular insights into heme homeostasis pathways in eukaryotes. In the present 
study, we report the identification of a novel catalog of genes that are regulated by 
heme at the transcriptional level. Further characterization of these genes is important 





Chapter 4 Characterization of C.elegans hrg-1 and hrg-4 
Summary 
 
We performed a transcriptional profiling experiment using Affymetrix C. 
elegans whole genome array and identified 288 heme-responsive genes. We 
postulated that expression of genes encoding for heme transporters might be higher at 
lower heme concentrations for maximum uptake of dietary heme. Therefore, we 
sorted the proteins encoded by the 80 hrgs that were upregulated at low heme into 
categories based on whether algorithms predicted the proteins to have transmembrane 
domains, transport functions and/or heme or metal binding motifs. We identified two 
genes, hrg-1 and its paralog hrg-4, that were highly heme responsive. Cehrg-1 has 
homologs in vertebrates, while Cehrg-4 is worm-specific. Using transcriptional GFP 
reporter constructs, we show that hrg-1 and hrg-4 localize to the intestinal cells of the 
worms. Depletion of hrg-4 in worms by RNA-mediated interference (RNAi) results 
in decreased ZnMP fluorescence in the gut and resistance to GaPPIX toxicity. In 
contrast, knock-down of hrg-1 by RNAi leads to an increased ZnMP fluorescence in 
the gut but causes no effects on animal viability using GaPPIX toxicity assays. 
Transient knockdown of hrg-1 in zebrafish results in hydrocephalus, yolk tube 
malformations and, most strikingly, anemia. Worm HRG-1 fully rescues all the 
phenotypes observed due to knock-down of hrg-1 in zebrafish. Ectopic expression in 
mammalian cells showed that HRG-4 localizes to the plasma membrane. Human and 
worm HRG-1 proteins localize together to the endo-lysosomal compartments. 
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CeHRG-1 and hHRG1 bind heme at lower pH and CeHRG-4 binds heme over a 
broader pH range. Studies conducted in Xenopus oocytes reveal that all three proteins 
transport heme. These results reveal an evolutionarily conserved role for HRG-1 
proteins. The work described here lays the foundation for delineating the molecular 
mechanisms for heme transport in metazoans using C. elegans as the animal model.  
Results 
Seeking to identify molecules involved in heme homeostasis, we conducted a 
genome-wide analysis using Affymetrix C. elegans whole genome array using RNA 
isolated from worms grown in mCeHR-2 medium containing 4, 20 or 500 μM heme 
and identified 288 heme-responsive genes (hrgs). We reasoned that in order to 
maximize heme uptake from the diet, the expression of genes that encode for putative 
heme transporters might be upregulated in heme-limiting conditions. There were 80 
hrgs that showed greater expression at 4 μM heme but were either down regulated or 
unchanged at 500 μM heme, compared to reference samples at 20 μM heme. From 
the microarray experiment, expression of F36H1.5 was upregulated greater than 10-
fold under low heme conditions but was undetectable at 500 μM heme. This gene was 
named heme-responsive gene-4 (hrg-4). RNA blotting and qRT-PCR analyses 
revealed that the hrg-4 mRNA level was significantly increased at 4 μM heme but 
was undetectable at 20 and 500 μM heme (Fig. 1a, b). We identified three putative 
paralogs in C. elegans, which we termed hrg-1 (R02E21.6), hrg-5 (F36H1.9) and 
hrg-6 (F36H1.10) with 27 %, 35 % and 39 % identity at the amino acid level, 
respectively (Fig. 2). Both hrg-1 and hrg-4 were highly heme responsive (Fig. 1a). 
The magnitude of upregulation of these genes at 1.5 μM heme and the response to 
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high heme concentrations, however, were markedly different (Fig. 1b and inset). Two 
paralogs, hrg-5 and hrg-6, did not show any heme-dependent changes in their level of 
expression. While hrg-4, hrg-5 and hrg-6 are nematode-specific genes, hrg-1 has 
putative homologs with ~ 25% amino acid sequence identity in vertebrates. The 
multiple sequence alignment obtained using Clustal W showed several conserved 
residues between worm HRG-1 and its vertebrate homologs (Fig. 3). The HRG-1 
proteins have conserved tyrosine (YxxØ) and acidic-dileucine based sorting signal 
(D/ExxxLL) in the cytoplasmic carboxy terminus [152]. The YxxØ motif is involved 
in rapid internalization of the proteins from the plasma membrane. This sorting motif 
has also been implicated in the targeting of transmembrane proteins to the lysosomes 
and sorting of proteins to the basolateral membrane in polarized cells [152]. The 
dileucine-based sorting signal plays an important role in sorting many type I, type II 
and multispanning membrane proteins. Like the tyrosine motif, D/ExxLL motif is 
also involved in internalization of proteins from the plasma membrane and targeting 
of proteins to the lysosomes.  
Topology modeling of HRG-1 and HRG-4 identified four predicted 
transmembrane domains (TMDs) (Fig. 4). We also identified residues that could 
potentially either bind heme directly such as the invariant histidine (H90 of HRG-1) 
in TMD2 or the FARKY (Y[A/S]HRY in vertebrates) motif in the C-terminus tail 
that could interact with the side chains of the heme moiety (Fig. 2-4). Studies in 
gram-negative bacteria have suggested an important role for histidine residues in the 
delivery of heme for cytochrome c biogenesis [153]. The invariant H90 of HRG-1 in 
TMD2 is substituted with a tyrosine (Y63) in HRG-4. Tyrosine heme ligand differs 
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from the histidines in that it has a lower redox potential and the coordination 
stabilizes heme from carrying out oxidative chemistry [154]. The tyrosine moiety in 
soluble guanylate cyclase has been shown to be involved in coordinating the 
propionate side chains in heme [153, 155, 156]. Based on the studies mentioned 
above, we postulate that the histidine in HRG-1 and tyrosine in HRG-4 may be 
involved in binding of heme by these proteins.  
To study the temporo-spatial expression patterns of hrg-1 and hrg-4, we 
generated transcriptional fusion constructs with GFP reporters to create integrated 
transgenic lines of C. elegans, either by gamma irradiation (IQ6011, hrg-1::gfp) or 
biolistics (IQ6041, hrg-4::gfp). Both these genes were expressed specifically in the 
intestinal cells in larvae and adults (Fig. 5a, b). The expression of GFP in transgenic 
worms with the hrg-4 transcriptional reporter was very weak. This can be attributed 
to the fact that biolistic transformation of C. elegans results in low-copy-number 
integrated lines [157]. As shown in Fig. 5, the levels of GFP expression can be 
modulated in a single generation of worms, by changing the amount of exogenous 
heme, suggesting that these worms can sense the amount of organismal heme. The 
expression of both hrg-1 and hrg-4 was regulated by exogenous heme and repression 
of these genes was specific to heme. Unlike the dramatic down regulation of GFP 
expression at 20 μM heme in the IQ6011 strain, there was only a modest decrease in 
GFP expression at 20 μM heme in the IQ6041 strain. This is consistent with the 
results from qRT-PCR data which showed that at a concentration of 15 μM heme 
where hrg-1 is already down regulated hrg-4 shows about 3-fold upregulation. 
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Neither protoporphyrin IX nor iron altered the expression of GFP in the IQ6011 or 
IQ6041 strains (Fig. 6a, b).  
We then assessed the effect of depletion of hrg-1 and hrg-4 in worms by 
RNA-mediated interference using the following assays: first, the expression of GFP 
in the hrg-1::gfp heme-sensor strain; second, the accumulation of fluorescent heme 
analog (ZnMP) and third, the sensitivity of animals to toxic heme analog, gallium 
protoporphyrin IX (GaPPIX), a toxic heme analog [93]. RNAi of hrg-1 resulted in a 
significant increase in GFP expression only at low heme levels in the heme sensor 
strain, but knockdown of hrg-4 resulted in the expression of GFP in the hrg-1::gfp 
worms at concentrations of heme that are usually sufficient to repress GFP expression 
(Fig. 7a). hrg-4 RNAi resulted in no accumulation of ZnMP in worms that were 
grown in 1.5 μM heme, a concentration sufficient for a robust uptake of heme in 
worms (Fig. 7b). Consistent with these observations, progeny of hrg-4 RNAi worms 
were resistant to GaPPIX toxicity (Fig. 7c). In contrast, hrg-1 depleted animals 
showed increased levels of ZnMP fluorescence when compared to control (Fig. 7b), 
and there was no discernable effect on animal viability using the GaPPIX toxicity 
assays (Fig. 7c). The GaPPIX toxicity assay was performed by Anita Rao (Hamza 
lab). The observed RNAi phenotypes of hrg-4 and hrg-1 suggest that HRG-4 is 
involved in uptake of heme into the worm intestinal cells whereas HRG-1 mediates 




Figure 1. Cehrg-4 and Cehrg-1 are upregulated at low heme concentrations 
a) Northern blot analysis of hrg-4 and hrg-1 expression in response to 4 and 20 μM 
heme in mCeHR-2 medium. The blot was stripped and reprobed with glyceraldehyde 
3-phosphate dehydrogenase (gpd-2) as a loading control b) Expression of hrg-4 
(circles) and hrg-1(squares) mRNA estimated by quantitative RT-PCR from total 
RNA obtained from worms grown at indicated heme concentrations. Each data point 
represents mean ± S.D and the results are representative of three experiments. Inset 
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Figure 2. CeHRG-4 paralogs in the C. elegans genome 
Multiple sequence alignment of CeHRG-1, -4, -5 and -6 paralogs obtained using 
ClustalW (v. 1.83). Identical amino acids and conservative changes are indicated by 
reversed and shaded characters, respectively. Asterisk indicates conserved histidines 
in HRG-1 that are replaced by tyrosines in HRG-4 and HRG-6.  Boxed residues 
denote the four putative transmembrane domains based on predictions from HRG-1.  
C-terminus tyrosine (YxxØ) and di-leucine (D/ExxxLL) based sorting motifs in 





Figure 3. CeHRG-1 has homologs in vertebrates 
Multiple sequence alignment of C. elegans HRG-1 with human (AAH65033.1), 
zebrafish (AAH53186.1), mouse (NP_080629.1), chicken (NP_001026574.1) and 
Xenopus (AAH82899.1) using ClustalW W (v. 1.83). Identical amino acids and 
conservative changes are indicated by reverse and shaded characters. Asterisk, 
histidine (H90); circles, aromatic amino acids; box, putative transmembrane domains; 





Figure 4. Predicted topology of C. elegans HRG-1 and HRG-4 
Putative topology of (a) C. elegans HRG-1, (b) hHRG1 and (c) C. elegans HRG-4 
predicted by TMHMM 2.0 and SOSUI. The amino and carboxy-termini are 
cytoplasmic, E1 and E2 are the exoplasmic loops and C1 is the cytoplasmic loop. 
Amino acids shaded red are potential heme binding residues and those in green and 
blue (CeHRG-1) are important for the intracellular localization of the protein. HRG-1 
proteins share certain characteristics with tetraspanin proteins, including polar 
residues (gray), and cysteines (orange) within TMDs that serve as putative 





















































































































































































































































































































































































































































Figure 5: IQ6011 hrg-1::gfp and IQ6041 hrg-4::gfp heme-sensor responds to 
exogenous heme 
L1 larvae of stable integrated transgenic line were sequentially exposed to mCeHR 
medium containing 2 μM heme (left and right panels) and 200 μM heme (center) a) 
hrg-1 promoter (3kb) was cloned into pPD95.67 plasmid that contained GFP 
preceded by a nuclear localization signal (NLS) and followed by the 3’ UTR from 
unc-54 to create a hrg-1::gfp transcriptional fusion. A stably integrated transgenic 
worm (IQ6011) was generated by injection of the hrg-1::gfp fusion construct 
followed by gamma irradiation b) 3kb promoter region of hrg-4 was fused to GFP 
preceded by a nuclear localization signal (NLS) and followed by the 3’ UTR from 
hrg-4 using Gateway Multisite recombination kit to create a hrg-4::gfp transcriptional 
fusion. A stably integrated transgenic worm (IQ6041) was generated by bombarding 
the hrg-4::gfp fusion construct along with gold particles into unc-119 temperature 
sensitive mutant strain. 
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Figure 6. Spectrometric analysis of GFP expression  
a) hrg-1::gfp (IQ6011) and b) hrg-4::gfp (IQ6041) worms were grown in mCeHR 
medium in the presence of indicated amounts of either heme, or heme supplemented 
with 20 μM protoporphyrin IX or 1 mM iron for two generations. Mixed population 
of worms from each treatment was harvested, and GFP fluorescence was quantified 





































































 BLAST searches revealed a homologous gene on zebrafish (Danio rerio) 
chromosome 6 (GenBank accession number BC053186) that shared approximately 
21% amino acid identity with C. elegans HRG-1. We used zebrafish to delineate the 
function of HRG-1. We reasoned that disruption in heme homeostasis would be 
manifested as hematological defects, which can be visualized by analyzing aberrant 
circulating erythroid cells in the transparent fish embryos [158]. Using whole-mount 
in situ hybridization, we show that zebrafish hrg-1 mRNA is expressed throughout 
the embryo including the central nervous system, at the 15-somite stage and 24 h post 
fertilization (See Appendix A). To knockdown hrg-1 in zebrafish, anti-sense 
morpholinos (MO) were designed at the splice junction of intron 2 with either exon 
1(MO1) or exon 2 (MO2) to induce mis-splicing and degradation of hrg-1mRNA. 
Embryos injected with MO1 exhibited mild anemia. By contrast, embryos injected 
with MO2 had severe anemia as discerned by the lack of o-dianisidine-positive 
erythroid cells (See Appendix A). MO2 morphants also showed other developmental 
defects, including hydrocephalus and a curved body with shortened yolk tube. The 
underlying cause of these discrepancies in phenotypes between MO1 and MO2 were 
revealed by RT-PCR which showed that MO2 caused exon-skipping resulting in a 
100 bp deletion in the open reading frame, while MO1 resulted in the reduction in 
mRNA levels due to mis-splicing (See Appendix A). We cloned the Cehrg-1 
construct into pCS2 (+) plasmid and confirmed its expression by transfecting into 
HEK 293 cells and checking on a SDS-PAGE gel. These constructs were sent to Dr. 
Barry Paw at Brigham Women’s Hospital for the rescue experiment. Despite only a 
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21% sequence identity between C. elegans and zebrafish HRG-1, co-injection of 
MO2 in the presence of C. elegans hrg-1 cRNA resulted in complete rescue of 
anemia phenotype and the developmental defects in hydrocephalus and curved body 
with shortened yolk tube (see Appendix A). The  phenotypes resulting from knock-
down of zebrafish hrg-1 was restricted specifically to the erythroid lineage and not to 
other hematopoietic- myeloid and thromboid lineages [127].  These studies suggest 
that both C. elegans and zebrafish HRG-1 are functionally equivalent and play a 
conserved role in maintaining heme homeostasis [127]. 
 To further delineate the role of HRG-1 in vertebrates, we examined its gene 
expression, intracellular localization and biochemical properties in mammalian cells. 
BLAST search identified a gene in the human genome database that is homologous to 
Cehrg-1, which we refer to as hHRG1 (SLC48A1). It is located on human 
chromosome 12q13 and is about 3.2 megabases from DMT1, the gene encoding for 
the primary ferrous iron transporter in mammals [159, 160]. RNA blotting in human 
adult tissues and cell lines detected two transcripts approximately 1.7 and 3.1 
kilobases in size (Fig. 8a, b). hHRG1 was highly expressed in the brain, kidney, heart 
and skeletal muscle (Fig 8a, c). hHRG1 was abundant in cell lines derived from 
duodenum (HuTu80), kidney (ACHN, HEK 293), bone marrow (HEL, K562) and 
brain (M17, SY5Y) (Fig. 8b, d).  
 We examined the effects of heme and iron status on hHRG1 gene expression. 
HEK 293 cells were grown for 14 h in heme-depleted medium with 500 μM succinyl 
acetone (SA) to inhibit heme synthesis and 100 μM desferroxamine (DFO) to chelate 
iron. Heme/iron depletion was followed by addition of 50 μM heme or 100 μM Fe-
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SIH to the cells for a period of 3 h. Cells were harvested and total RNA was isolated. 
We performed qRT-PCR assays and found that the levels of hHRG1 mRNA were 
unaltered. There was significant upregulation of HMOX1 (gene encoding for heme 
oxygenase) under heme-replete conditions and Tfr1 (gene encoding for transferring 
receptor 1) during iron-starvation (Fig 9a). To determine whether mHrg-1 gene 
expression was regulated at the transcriptional level by heme during erythroid 
maturation when the demand for heme is enormous, we used Friend mouse 
erythroleukemia (MEL) cells. MEL cells can be induced with 1.5 % DMSO to 
produce hemoglobin thereby simulating erythroid maturation. Induction of 
hemoglobin production in MEL cells resulted in the expected increase of globin and 
Alas-2 mRNA but did not alter Hrg-1 mRNA expression (Fig. 9b, c). These results 
revealed that unlike the worm homolog, hHRG1 does not respond to changes in heme 
status at the transcriptional level. However, these findings do not exclude the 
possibility that HRG-1 may be regulated at the post-transcriptional level.  
 To examine the localization and function of HRG-1 proteins, we made fusion 
constructs of CeHRG-1, hHRG1 and CeHRG-4 with either the hemagglutinin (HA) 
epitope or GFP variants at the N and C-terminus and transiently transfected these 




Figure 7. hrg-1 and hrg-4 are essential for heme homeostasis in C. elegans 
a) Equal numbers of synchronized L1 larvae from IQ6011 worms were grown in 
mCeHR-2 medium supplemented with 10 μM heme and plated on NGM agar plates 
spotted with RNAi feeding bacteria that was grown in the presence of either 5 or 25 
μM heme. After 96 h of exposure to double-stranded RNA from the control vector, 
hrg-1 or hrg-4, images were captured and the relative GFP fluorescence intensities 
were estimated using Simple PCI. Within each treatment, values with different letters 
are significantly different (P<0.001), as determined by using a one-way ANOVA 
with Student–Newman–Keuls multiple comparisons test.  Each data point represents 
the mean ± SEM and the results are representative of five separate experiments (n= 
35-45 worms per treatment). b) RNAi feeding was performed for 72 h using N2 
worms initially grown in 10 μM heme containing mCeHR-2 medium. Following 
RNAi, worms were washed and incubated in mCeHR-2 medium containing 1.5 μM 
heme and 10 μM ZnMP for 16 h. Fluorescence images were captured using a 
Rhodamine filter and relative ZnMP fluorescence intensities from ~ 50 worms from 
each treatment were estimated using SimplePCI. c) Worms were first subjected to the 
indicated bacteria for RNAi and subsequently transferred to fresh NGM agar plates 
containing 1 µM GaPPIX plus RNAi bacteria. The total number of eggs that resulted 
in viable larvae was estimated after 5 days of exposure to GaPPIX. Each data point 
represents the mean ± SD and the results are representative of four separate 









































































  While the proteins tagged with HA or GFP at the N-terminus were unstable, 
C-terminally tagged proteins were stable. On the SDS-PAGE gel, all three proteins 
migrated as monomers and other slowly migrating oligomers (Fig. 10). In vitro 
transcription and translation experiment of CeHRG-1, hHRG1 and CeHRG-4 
conducted by Caitlin Hall (Hamza lab), revealed a single band on the SDS-PAGE 
corresponding to the monomer for each of the three proteins suggesting that the 
oligomerization did not occur in solution either due to overexpression of these 
proteins or after cell lysis (Fig. 10) [127].  To examine the intracellular localization of 
these proteins, we performed confocal microscopy studies with cells expressing 
fluorescently tagged proteins. These studies revealed that HRG-4 was on the 
periphery of the cells and it localized with the plasma membrane marker wheat germ 
agglutinin conjugated with Alexa Fluor 633. CeHRG-1 and hHRG1 were primarily 
distributed in an intracellular compartment throughout the cytoplasm, with the 
remaining approximately 10% of the total fluorescence on the cell surface (Fig. 11a). 
CeHRG-1 and hHRG1 colocalized to the same intracellular regions in cells. Studies 
with organelle markers localized these proteins with LAMP1 (a 120kD lysosomal 
membrane glycoprotein) and to a lesser extent with Rab 7 (a Rab GTPase involved in 
transport of proteins from early endosomes to late endosomes) and Rab11 (a Rab 
GTPase involved in the export of membrane proteins from the golgi through the 
endosomes and apical and basolateral endocytic recycling)  (Fig. 11b) [161, 162]. 
Because the worm and human HRG-1 proteins localize to a low pH, endo-lysosomal 
compartment, we conducted heme-binding studies at pH 6.0 and 8.5. Heme-binding 
to CeHRG-1 and hHRG1 was greatly increased at the lower pH range (See Appendix 
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B). CeHRG-4, however, bound heme across a broader pH range. These findings are 
consistent with the intracellular localization of the HRG-1 proteins. Worm and human 
HRG-1 co-localize to an acidic endo-lysosomal compartment and, therefore, it makes 
physiological sense that binding of HRG-1 to heme was significantly improved by 
lowering the pH, as compared to CeHRG-4 which localizes to the plasma membrane 
and binds heme over a broader pH range.  
To investigate whether HRG-1 proteins are heme transporters, we cloned 
Cehrg-1, Cehrg-4 and hHRG1 into pT7Ts plasmid for expression in Xenopus laevis 
oocytes. These constructs were sent to Dr. M. Matthew to conduct 
electrophysiological studies in Xenopus oocytes. Oocytes were injected with cRNA 
for all three constructs and currents were monitored under a two-electrode voltage 
clamp at pH 7.5. Significant heme-induced inward currents were observed only in the 
presence of 20 μM hemin for oocytes injected with cRNA for CeHRG-1, hHRG1 and 
CeHRG-4 but none in control oocytes that were injected with the human potassium 
channel (hKv1.1).  These results are indicative of heme-dependent transport across 





Figure 8. Expression of human HRG1 
a) mRNA expression of human HRG1 in multiple adult human tissues (PBL, 
peripheral blood leukocytes) b) mRNA expression of human HRG1 in tissue-derived 
cell lines. The blots were stripped and reprobed with β-actin as loading control. 
Relative hHRG1 mRNA levels by RNA blots of human tissues (c) and cell lines (d) 
quantified by ImageQuant v 2.2. hHRG1 mRNA was normalized to the loading 










Figure 9. Expression pattern of HRG-1 in cultured cells.   
a) hHRG1 mRNA levels were unaltered by heme or iron depletion in cultured HEK293 
cell lines.  Cells were either grown in basal growth medium or in the presence of heme-
depleted medium (HD), 500 μM succinyl acetone (SA) to inhibit heme synthesis, and 
100 μM desferroxamine (DFO) to chelate iron.  After 14 h of heme/iron depletion, cells 
were exposed to either 50 μM heme or 100 μM iron-SIH for 3 h.  Total RNA was 
extracted from cells and processed for qRT-PCR using primers designed to amplify 
cDNA for hHRG1, heme oxygenase (HMOX1) and the transferrin receptor (TfR1).  
Gene-specific fold induction was quantified by normalizing to GAPDH as the loading 
control.  (***, P < 0.001 and *, P < 0.05 between basal conditions and the indicated 
treatment).  Mean values were calculated and differences were compared by using the 
Student–Newman–Keuls multiple comparison test and one-way ANOVA. b) mHrg-1 
mRNA is not induced during erythroid maturation in cultured mouse erythroleukemia 
(MEL) cells.  MEL cells (DS19 clones) were induced with 1.5 % DMSO (v/v) which 
results in appearance of o-dianisidine positive cells, a marker of hemoglobinization.  
mHrg-1 mRNA was unaltered in MEL cells 72 h post differentiation compared with α-
globin (Hba-a1), β-globin (Hbb-b1), and Alas-2 mRNA. c) Time-dependence of 
mRNA expression as a function of erythroid maturation in MEL cells.  mHrg-1 
expression does not vary during MEL cell differentiation.  Total RNA obtained from 
MEL cells harvested at the specific time points after induction with DMSO were 
quantified for Hrg-1 mRNA expression using qRT-PCR and normalized to Gapdh as 
the loading control.  Each data point represents the mean ± SEM and the results are 










Figure 10. Expression of HRG-1 proteins in HEK 293 cells 
Cell lysates from HEK 293 cells transfected with C-terminally tagged CeHRG-1, 
hHRG1 and CeHRG-4 were resolved by SDS-PAGE, and the proteins were detected 
by immunoblotting with antibodies against HA (lanes 1-3, 50 μg) and GFP (lanes 4-6, 
25 μg) or by 35S fluorography using an in vitro cell-free wheat germ expression 






Figure 11. Localization of HRG-1 proteins in HEK 293 cells 
a) Cellular localization of C-terminally tagged fluorescent proteins in transfected 
HEK 293 cells by confocal microscopy. The plasma membrane (PM) was identified 
using wheat germ agglutinin. b) Localization of CeHRG-1 with organelle markers as 































Our results show that HRG-1 and HRG-4 are involved in mediating heme 
homeostasis in C. elegans, an organism that relies on exogenous heme for its growth 
and development [93]. Using cell biological and biochemical approaches in C. 
elegans and zebrafish, we have identified and established HRG-1 as a conserved 
protein with an important role in heme metabolism. Studies in zebrafish reveal that 
HRG-1 is important for the maintenance of hematopoietic cells and for specification 
of the central nervous system during embryonic development. The mild anemia 
exhibited by MO1 morphants suggests that lowering of HRG-1 levels in tissues such 
as developing erythrocytes that have a greater requirement of heme, results in a 
tissue-specific phenotype and, therefore, can be useful in understanding the role of 
HRG-1 in hematopoiesis. The complete phenotypic rescue of zebrafish MO2 
morphants by worm HRG-1 shows that these proteins are functional orthologs with 
conserved roles in heme homeostasis.  
We hypothesize, that because C. elegans relies solely on exogenous heme, 
there might be compensatory mechanisms to maintain heme homeostasis. This is a 
physiologically reasonable argument because, unlike knock-down of HRG-1 in 
zebrafish that results in severe phenotypes, depletion of hrg-1 or hrg-4 by RNA-
mediated interference in worms does not result in any obvious effect on growth and 
development. The worm genome encodes for four paralogs (hrg-1, -4, -5 and -6) that 
might play overlapping roles since these proteins have conserved amino acids and 
similar putative membrane topology. Further studies need to be done to examine 
whether HRG-1 paralogs play functionally conserved roles in heme metabolism.  
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 The amino acid sequence and the predicted topology of these proteins provide 
clues as to how HRG-1 proteins function in heme homeostasis. While HRG-1 has 
tyrosine-based and acidic-dileucine based motifs that have been shown to be 
involved in the sorting of membrane proteins to endosomes and lysosome-related 
organelles, HRG-4 lacks these residues [152]. Interestingly, HRG-1 has a histidine 
residue at position 90 in the second transmembrane domain, and this histidine is 
replaced by a tyrosine in HRG-4. Since HRG-4 localizes to the plasma membrane it 
is more likely to encounter heme in an oxidized form. It has been shown that 
replacing the histidine residue with a tyrosine heme-binding ligand in proteins 
mitigates the reactivity of heme, possibly due to the ability of Tyr to stabilize 
oxidized forms of heme [163]. It is reasonable to speculate that the Tyr and His 
residues in TMD2 of HRG-4 and HRG-1, respectively, are important determinants 
of the function of these proteins.  
 Moreover, HRG-1 proteins share some of the features found in tetraspanins 
including polar residues within the transmembrane domains and cysteines within 
TMDs that serve as membrane-proximal palmitoylation sites [164]. Tetraspanins 
have been shown to organize laterally in tetraspanin-enriched microdomains (TEM). 
A biochemical feature of the TEM is that the tetraspanin proteins and their partners 
tend to remain associated under non-stringent detergent conditions [164]. 
Cholesterol has also been shown to associate physically and functionally with TEMs. 
This is particularly interesting because HRG-1 proteins migrate as oligomers on an 
SDS-PAGE gel under non-heat denatured conditions and it is possible that these 
oligomers are, in fact, heterodimers of HRG-1 and other interacting proteins. It will 
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be interesting to test the effects of cholesterol-depletion and the putative 
palmitoylation-site mutations on the localization, oligomerization and function of 
HRG-1 proteins. 
 Based on the RNAi phenotypes, sub-cellular localization, biochemical assays, 
and amino acid sequence analysis of the HRG-1 proteins, we propose that HRG-4 
mediates heme uptake from the plasma membrane in C. elegans and HRG-1 
modulates intracellular heme availability through a vesicular compartment (Fig. 12).  
Our model is physiologically reasonable because heme-limiting conditions would 
induce uptake and sequestration of the essential but toxic molecule through the 
coordinated functions of HRG-1 and HRG-4. Although HRG-4 appears to be 
specific to worms, the zebrafish studies demonstrate that regulation of heme 
homeostasis by HRG-1 is conserved in animals that synthesize heme. Since reduced 
levels of HRG-1 in MO1 morphants results in anemia, we speculate that 
hypomorphic alleles of hrg-1 on human chromosome 12q13 might be an important 
determinant in congenital types of anemias. 
 The discovery of hrg-1 and hrg-4 as heme transporters provides molecular 
insights into eukaryotic heme homeostasis. Further studies need to be done in order 
to fully understand how organisms delicately balance intracellular levels of heme-an 




Figure 12. Proposed model of heme homeostasis in C. elegans 
 Expression of hrg-1 and hrg-4 is upregulated under heme-limiting conditions. HRG-4 
is localized on the plasma membrane and HRG-1 is found in an intracellular endo-
lysosomal compartment. The expression hrg-1 and hrg-4 is down regulated at high 
heme, possibly preventing uptake of the toxic macrocycle, heme, under heme-replete 










We have previously demonstrated that HRG-1 and its worm-specific paralog 
HRG-4 are heme transporters in worms [127]. Here we show that, in worms, HRG-1 
and HRG-4 are expressed in worm intestinal cells albeit with different localization 
patterns. HRG-4 localizes to the plasma membrane of polarized intestinal cells, while 
HRG-1 localizes to an intracellular compartment with the fluorescent heme analog 
ZnMP. To better understand hrg-1 and hrg-4 functions, we characterize the deletion 
mutants of hrg-1 and hrg-4. While the ∆hrg-1 (tm3199) strain is a null mutant, we 
found that ∆hrg-4 (tm2994) is not a null strain. The ∆hrg-1 worms have decreased 
ZnMP fluorescence in their gut and increased resistance to GaPPIX, whereas the 
∆hrg-4 animals show increased ZnMP fluorescence uptake and sensitivity to 
GaPPIX. These findings are diametrically opposite to the previous observations made 
by depleting hrg-1 and hrg-4 using RNA-mediated interference. Nearly 80% of the 
∆hrg-1 animals exhibit defects in embryogenesis concomitant with a decrease in 
brood size. We observe a similar decrease in brood size in the ∆hrg-1 brood mate 
control animals. In contrast, the ∆hrg-4 worms appear normal. We speculate that the 
deletion strains may have developed mechanisms to compensate for the lack of hrg-1 
and hrg-4. Results from qRT-PCR analysis reveal aberrant gene expression profiles 
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of the hrg-4 paralogs, hrg-5 and hrg-6, in the homozygous deletion animals and their 
brood mate controls. Since these findings are preliminary, further characterization is 
needed to determine how useful these deletion strains will be in delineating the in 




We have demonstrated that HRG-1 proteins (CeHRG-1 and CeHRG-4) are 
heme transporters and have a conserved role in regulating heme homeostasis. To 
elucidate the function of these proteins in vivo, we synthesized Cehrg-1 and Cehrg-4 
transcriptional constructs by fusing the ~3 kb promoter region of these genes with 
GFP containing a nuclear localization signal and an unc-54 3’UTR. We generated 
transgenic worms stably expressing the transcriptional constructs by injection 
followed by gamma irradiation (Cehrg-1) or by biolistics (Cehrg-4). Analysis of these 
transgenic worms revealed that both Cehrg-1 and Cehrg-4 are expressed specifically 
in the intestinal cells (Chapter 4, Fig. 5) 
While the transcriptional fusion reporters are useful for studying the spatial 
expression patterns of these genes, they do not provide any information on the in vivo 
localization of the proteins. In order to make translational reporter constructs, we first 
confirmed the predicted exon-intron boundaries and the 5’ and 3’ untranslated regions 
of both Cehrg-1 and Cehrg-4. Using the 5’ RACE reaction, we identified 3 different 
transcripts including one SL1 transcript, for Cehrg-1. The 5’ RACE reaction for hrg-4 
was performed at least four times but we were not successful in identifying the 
transcriptional start site. We therefore used a PCR based approach using the hrg-4 
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primer with SL1 or SL2 primers and found a SL1 transcript for Cehrg-4, which was 
about ~ 777 bp in length (Fig. 1). The 3’-UTRs identified using 3’ RACE reactions 
were ~190 bp and ~60 bp for Cehrg-1 and Cehrg-4, respectively.  
To construct a translational fusion, we used the Gateway technology using 
Multisite recombination (Invitrogen). The 3 kb promoter region of the hrg-1, Cehrg-1 
genomic region (exons and introns) and the gene for GFP (from the Fire vector kit 
plasmid pPD95.75) fused to the 3’ unc-54 UTR were cloned into three separate 
plasmids by recombination. All three entry plasmids were assembled by multisite 
recombination. The process was repeated for Cehrg-4, but, instead of GFP and unc-
54 3’ UTR, we used the gene for YFP fused with hrg-4 3’ UTR. These plasmids were 
bombarded into unc-119 strain along with the unc-119 rescue plasmid to generate 
three stably expressed lines for hrg-1 and two stably expressed lines for hrg-4. 
Analysis of the transgenic lines stably expressing the HRG-1 and HRG-4 constructs 
using Zeiss 510 confocal microscope revealed that both proteins were found in the 
intestinal cells. These results are consistent with the expression pattern for hrg-1 and 
hrg-4 in the transgenic worms (IQ6011 and IQ6041) stably expressing the 
transcriptional reporter constructs for these genes. Although both proteins were 
expressed in the intestinal cells, HRG-1 localized to an intracellular compartment 
while HRG-4 was expressed on the lumenal surface (Figs. 2 and 3). To further 
delineate the difference in localization, the transgenic worms were incubated for 16 
hours in axenic mCeHR-2 medium containing 2 μM heme and 10 μM ZnMP, the 
fluorescent heme analog. ZnMP localized within the vesicles that were expressing 
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HRG-1::GFP and there was no colocalization of ZnMP with HRG-4::YFP (Fig. 2 and 
3).  
The transcriptional and translational reporter constructs revealed the spatial 
expression patterns of hrg-1 and hrg-4, but to understand the in vivo functions of the 
HRG-1 proteins, we obtained deletion alleles tm3199 (∆hrg-1) and tm2994 (∆hrg-4) 
from the National Bioresource Project (Japan). As shown in Figure 4, ∆hrg-1 
(tm3199) has a 341 bp deletion in hrg-1 that removed exon 1 (including ~ 60 bp of 
the hrg-1 promoter upstream of the ATG start codon), intron 1 and a portion of exon 
2. The ∆hrg-4 (tm2994) is missing 202 bp from intron 1, exon 2 and intron 2 (Fig. 
4a). Both the ∆hrg-1 and ∆hrg-4 strains were backcrossed eight times with the wild 
type N2 strain to generate homozygous deletion strains (∆hrg-4, IQ6910; ∆hrg-1, 
IQ6912). Because deletion strains may have multiple deletions that can be difficult to 
outcross, we used brood mates that were wild-type for hrg-1 and hrg-4 as the “wild-
type” controls (IQ6909 and IQ6911). To confirm the presence of the deletion, we 
isolated the genomic DNA and total RNA from these worms for PCR analysis. Using 
the primers that were designed around the deleted regions in hrg-1 and hrg-4, we 
performed PCR analysis followed by agarose gel electrophoresis. PCR analysis of the 
genomic DNA obtained from the ∆hrg-1and ∆hrg-4 showed a 341 bp and 202 bp 
deletion in hrg-1 and hrg-4 respectively (Fig. 4b). To determine if either of these 
strains were null mutants, we synthesized cDNA using total RNA isolated from the 
two strains. Using PCR, we observed a very faint product ~ 650 bp in the ∆hrg-1 
strain and ~450 bp product in the ∆hrg-4 strain. Since the product in the ∆hrg-1 strain 
was barely visible after 40 cycles of amplification using PCR, it is highly likely that 
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∆hrg-1 (tm3199) is a null mutant. But our results from the PCR analysis of hrg-4 
using total RNA isolated from the ∆hrg-4 strain suggests that ∆hrg-4 (tm2994) is not 
a null strain (Fig. 4c). The predicted amino acid sequence for HRG-4 in the ∆hrg-4 
mutant animals is shown in Fig. 4d. If the mRNA is translated, then a truncated HRG-
4 protein with the first two transmembrane domains will be synthesized in the ∆hrg-4 
animals. 
We have previously shown that depletion of hrg-1 and hrg-4 by RNAi in 
worms resulted in aberrant heme homeostasis [127]. To test if the hrg-1 and hrg-4 
deletion strains phenocopy the RNAi results, we used heme analogs, ZnMP and 
GaPPIX. We found that the ∆hrg-1 strain showed a decreased ZnMP fluorescence 
and the ∆hrg-4 worms had increased ZnMP when compared to N2 or the wild-type 
brood mates (Fig. 5). When these worms were fed the toxic heme analog, GaPPIX, 
we found that ∆hrg-4 animals (IQ6910) were more sensitive than the brood mate 
control worms (IQ6909). The ∆hrg-4 worms laid fewer progeny than IQ6909 worms 
at 1 μM GaPPIX (Fig. 6). By contrast, ∆hrg-1 worms (IQ6912) showed resistance to 
GaPPIX in that these animals laid more progeny than the brood mate controls 
(IQ6911). While our results suggest that there is dysregulation of heme homeostasis 
in deletion strains, these findings are not consistent with the phenotypes that were 
observed for the knock-down of hrg-1 and hrg-4 by RNA- mediated interference in 
either N2 or IQ6011 heme-sensor strain. 
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Figure 1. Genomic structure of hrg-1 and hrg-4  
(a) RACE PCR analysis of Cehrg-1 revealed (1) a SL1 transpliced transcript ~ 900 
bp, (2) ~ 2890 bp transcript (3) ~8 kb transcript. All three transcripts had a ~ 190 bp 
3’ UTR. (b) Cehrg-4 has one transcript, a SL1 spliced transcript that was determined 
to be 777 bp long by PCR analysis. 3’ RACE PCR was used to determine that Cehrg-
4 has a 3’ UTR of ~ 60 bp. Exons are indicated by open boxes and introns are 
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Figure 2. HRG-1 localizes to vesicular compartments in the intestine. 
(a) Schematic representation of the hrg-1::gfp translational construct. (b) In the 
transgenic worms (IQ6111) stably expressing the HRG-1::GFP translational fusion 
construct, fluorescent heme analog ZnMP (red) and HRG-1::GFP (green) localize to a 
vesicular compartment in intestinal cells. (c) For clarity, the boxed region in the 
merge image has been enlarged. Images were obtained with a Zeiss 510 confocal 












Figure 3. HRG-4 localizes to the intestinal lumenal surface. 
(a) Schematic representation of the hrg-4::gfp translational construct. (b) In the 
transgenic worms (IQ6141) stably expressing the HRG-4::YFP translational fusion 
construct, fluorescent heme analog ZnMP (red) localizes to a vesicular compartment 
in intestinal cells while HRG-4::YFP (green) localizes to the lumenal surface of the 
intestinal. (c) For clarity, the boxed region in the merge image has been enlarged to 
show that ZnMP and HRG-4::YFP are found in different regions of the intestine. 













Figure 4. Analysis of the ∆hrg-1 (tm3199) and ∆hrg-4 (tm2994) deletion strains. 
(a) Schematic representation of tm3199 and tm2994. Open boxes represent exons and 
lines indicate introns. The size of each exon and intron is indicated. The deletion 
region is also represented. The red arrows represent the primers that were used to 
screen for homozygous deletion animals. (b) PCR analysis of genomic DNA obtained 
from wild-type N2 worms (lanes 2 and 4) and homozygous mutants. hrg-1 specific 
primers were used in lanes 2 and 3; hrg-4 primers were used for lanes 4 and 5. (c) 
PCR screening of cDNA synthesized from total RNA isolated from wild-type N2 
worms and homozygous mutants. The hrg-1 primers were used for lanes 2 and 3; hrg-
4 primers were used for lanes 4 and 5. (d) DNA sequence for tm2994 along with 
predicted amino acid sequence of the RT-PCR product. The boxed region indicates 
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  While RNAi of hrg-1 and hrg-4 in IQ6011 or N2 did not reveal any 
discernable developmental defects, we reasoned that since the deletion strains lack 
HRG-1 heme transporters, the deletion animals might exhibit growth and/or 
developmental defects. This is a reasonable argument because we have previously 
demonstrated that heme is essential for worm reproduction and development. 
Therefore, abolishing heme uptake and transport could have an effect on growth and 
development of worms. Using a Leica DMIRE2 epifluorescence/ DIC microscope, 
we analyzed the deletion worms for morphological defects. We found that only ∆hrg-
1 animals show embryonic defects. About 80% of these animals had defects including 
an inability to lay embryos, persistence of embryo-like structures and, in many cases, 
the animals would have only one or two 4-cell stage embryos (Fig. 7a and b).  
We postulated that such embryonic defects in these animals might lead to 
lower fecundity and, therefore, conducted a brood size experiment to determine the 
total number of progeny. Ten individual worms were placed individually on NGM 
agar plates and were allowed to lay progeny for a period of 6 days. We counted the 
total number of progeny laid every two days. Although there was a decrease in the 
total number of progeny laid by ∆hrg-1 animals, we found that the brood mate control 
animals also had a reduction in brood size (Fig. 8). Importantly, only ~20% of brood 
mate control animals exhibited embryonic defects similar to the ∆hrg-1 worms (Fig. 
7). 
A possible explanation for the discrepancies observed in the phenotypes in 
deletion worms versus the depletion of hrg-1 and hrg-4 in N2 worms by RNAi is that 
there may be an adaptive response concomitant with a global change in the 
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expression profiles of genes involved in heme homeostasis in the hrg-1 and hrg-4 
deletion strains. Sequence analysis of hrg-4 had revealed two other paralogs in 
worms, hrg-5 and hrg-6. Although hrg-5 and hrg-6 were not heme-responsive, we 
reasoned that these genes might be providing the compensatory mechanisms for heme 
uptake in the worms that lack hrg-1 or hrg-4. Using RNA isolated from ∆hrg-1, 
∆hrg-4 and the wild-type brood mates, we performed qRT-PCR assay. There was a 
down regulation of hrg-1, hrg-5, or hrg-6 in the ∆hrg-4 worms, and a down 
regulation of the hrg-6 mRNA levels ∆hrg-1 strain (Fig. 9). This modest decrease in 
levels of hrg-1, hrg-5 and hrg-6 in the ∆hrg-4 worms and the decrease in hrg-6 levels 
in the ∆hrg-1 worms do not explain why these worms have decreased ZnMP uptake 
and increased resistance to GaPPIX.  Also, there is an increased expression of hrg-6 
in IQ6911 wild-type brood mate and an increase in the levels of all three hrgs in the 
case of IQ6909 (Fig. 9). This finding suggests that even after eight backcrosses there 
might still be other mutations in the background of these strains that are causing the 
differences between wild-type siblings and the wild-type N2 strain. It is also possible 
that the ∆hrg-4 worms are upregulating some of the other heme-responsive genes that 
might be involved in heme uptake. 
 
Discussion  
From our heme microarray analysis, we have identified Cehrg-1 and hrg-4 as 
heme-responsive genes that were highly upregulated at lower heme conditions. Using 
various genetic, biochemical and cell biological approaches, we have characterized 
the HRG-1 and HRG-4 proteins as heme transporters. We have previously shown that 
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in mammalian cells HRG-4 localized to the plasma membrane and HRG-1 was found 
on endo-lysosomal compartments. In mammalian cells, HRG-1 co-localized with 
LAMP-1 and we found that HRG-1 bound heme under acidic pH. Using transgenic 
worms stably expressing HRG-1::GFP and HRG-4::YFP translational constructs, we 
showed that HRG-4 localized to the lumenal surface and HRG-1 was found on 
membranes of vesicles in the intestinal cells. These vesicular compartments might be 
the birefringent, autofluorescent intestinal organelles called gut granules [165]. The 
gut granules in worm intestine have been shown to be a lysosome-related organelle 
[166]. Several proteins including GLO-1, an intestine-specific Rab GTPase, VHA-11, 
a vacuolar-ATPase that has been shown to be involved in the acidification of cellular 
compartments, and LMP-1, the C. elegans homolog of mammalian lysosome-
associated membrane protein or LAMP, have been shown to be associated with the 
granules [165-168]. Knock-down of gut granule associated proteins such as VHA-11 
in the IQ6111 strain and analysis of the HRG-1::GFP localization might be important 
in determining the cellular components that are responsible for proper targeting of 
HRG-1 coincident with ZnMP localization. 
While RNAi depletion of hrg-4 resulted in decreased ZnMP uptake and 
resistance to toxic GaPPIX, the ∆hrg-4 animals showed an increase in ZnMP 
fluorescence and were sensitive to GaPPIX. Contradicting results were also observed 
for ∆hrg-1 animals that had lower level of ZnMP and showed resistance to GaPPIX. 
Although it is possible that the RNAi results were due to off target effects, our RNAi 
experiments were conducted with multiple RNAi constructs targeting different parts 
of hrg-1 and hrg-4. Another possibility is that RNAi by feeding transiently knocks-
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down genes that are not sustained through multiple generations. Knock-out of genes 
by deletion is permanent and provides an opportunity for the animals to adapt to 
abnormal changes in the environment. Thus, it is possible that these animals have 
developed other compensatory mechanisms for heme uptake and sequestration. 
Therefore, it would be very interesting to identify differences in gene expression 
profiles between these mutants and the wild type strain using a global transcriptional 
profiling study. It is also possible that there are gene rearrangements or duplications 
in addition to the deletion of either hrg-1 or hrg-4 in these mutants. Thus, the 
phenotypes of ∆hrg-1 and ∆hrg-4 animals may be synthetic to these other spurious 
deletions. 
The ∆hrg-4 mutants did not exhibit any morphological defects. This could be 
attributed to the fact that these animals are probably making a truncated form of 
HRG-4. An in vitro transcription-translation assay might be useful to determine 
whether a protein can be translated and if so is it stable or functional in yeast or 
Xenopus assays. 
We observed that ~80% of ∆hrg-1 homozygous animals showed embryonic 
defects including the “bag-of-worms” phenotype. We also observed that ~25% of the 
∆hrg-1 wild-type brood mate animals had similar phenotypes. It is possible that these 
mutants are still harboring other mutations in their background, despite eight 
backcrosses, that are causing these embryogenesis defects. Therefore, it is important 
to ensure that the phenotypes observed are due to the deletion in hrg-1. This can be 
done by injecting these animals with a hrg-1 rescue construct containing the 3 kb hrg-
1 promoter, hrg-1 gene (exons and introns) fused to GFP and the unc-54 3’ UTR. 
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We have a Mos-1 transposon insertion available for hrg-4 (ttTi 10386) which 
encompasses the first intron and further characterization of this Mos-1 insertion allele 
will provide clues as to whether the tm3199 allele for hrg-4 is a null strain or a 
hypomorph. We are generating ∆hrg-1 and ∆hrg-4 double mutants but there have 
been problems with mating these strains. It is possible that there might be defects in 
the development of males from these homozygous strains. Analysis of the ∆hrg-1 and 
∆hrg-4 double mutant strain and experiments including heme dose-response assays 
for the single and double mutants need to be conducted in order to characterize the 
deletion strains completely. The double deletion strain might provide a tractable 
animal model of abnormal heme homeostasis that could be exploited to further 
understand organismal heme metabolism by transformation of this strain with HRG-1 
and HRG-4 mutant and chimeric proteins.  
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Figure 5. Deletion strains have aberrant ZnMP uptake 
Worms grown on NGM agar plates spotted with OP50 were transferred to liquid 
axenic mCeHR-2 medium with 2 μM heme and 10 μM ZnMP. After overnight 
incubation at 20ºC, worms were photographed using Leica DMIRE2 epifluorescence/ 
DIC microscope fitted with a 10X objective lens. Images were quantified using 
SimplePCI software (mean ± S.E.M, n= 100). The deletion strains were compared to 
the respective wild-type brood mate animals. Student-Neuman-Keul’s was used to 


















































Figure 6. Deletion strains show an abnormal response to GaPPIX 
Fifteen L4 larval stage worms of the strains indicated, were added to each well in a 
24-well plate containing NGM agar with 1 μM GaPPIX and spotted with OP50 
bacteria. The total number of live progeny was counted 36 h after GaPPIX exposure. 







































Figure 7. Morphological defects in the deletion strains (a) N2, IQ6909, IQ6910, 
IQ6911 and IQ6912 worms were picked on to agar pads, anesthetized using 10 mM 
levamisole and analyzed using Leica DMIRE2 epifluorescence/ DIC microscope. 
DIC images of the morphological defects were obtained using a CCD camera fitted to 
the Leica DMIRE2 epifluorescence/ DIC microscope. Images were taken using 40X 
objective lens. Embryo-like structures (asterisk) and bag-of-worms (arrow heads) are 
indicated. (Scale Bar = 20 μm) (b) Each worm was scored for phenotypes indicated in 
the graph (n = 40-50 per strain). The percentage of number of worms with defects 




























































































































Figure 8. Brood size of the deletion strains  
Ten gravid worms from each of the strain as indicated in the graph, were placed 
individually on NGM agar plates spotted with OP50 grown in LB with no added 
heme (open bars) or in LB with 100 μM heme (gray bars). The worms were allowed 





























Figure 9. Aberrant gene expression profiles of the hrg-4 paralogs in the deletion 
strains 
 (a) Real-time PCR analysis of hrg-1, hrg-5 and hrg-6 in the following strains: N2, 
IQ6909 (∆hrg-4 wild-type brood mate) and ∆hrg-4. (b) Real-time PCR analysis of 
hrg-4, hrg-5 and hrg-6 in N2, IQ6911 (∆hrg-1 wild-type brood mate) and ∆hrg-1. 
Data were compared to gpd-2 levels in each strain and the fold change was calculated 
using 2(-∆Ct) method. The p-values were calculated using One-way ANOVA and 


















































































Chapter 6  Conclusions and future directions 
Conclusions 
 
The goal of this project was to identify specific molecules and pathways involved in 
heme uptake, transport and sequestration. C. elegans is a unique animal model in 
addressing questions related to regulation of heme homeostasis because it lacks the 
ability to synthesize heme and relies solely on exogenous heme for normal growth 
and development [93]. This unique aspect of C. elegans permitted, for the first time, 
the control of internal heme by dietary means, and we performed a genome-wide 
analysis using Affymetrix C. elegans whole genome arrays to identify genes that 
were regulated at a transcriptional level by heme. The major findings from this body 
of work are listed and discussed below. 
1) Using the Affymetrix C. elegans whole genome arrays, we identified 288 
heme-responsive genes (hrgs). Of these, 84 had homologs specific to humans. 
This finding is significant because it suggests that there might be pathways 
common to both worms and humans for maintaining intracellular levels of 
heme and the results from studies conducted using C. elegans as an animal 
model may be extrapolated to humans. We also identified 12 heme auxotroph-
specific homologs. This is important because it suggests that the heme 
acquisition pathways may share commonalities between C. elegans and 
parasites that lack the ability to synthesize heme. Characterization of these 
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genes might enable the design of new drug targets to tackle parasitic 
infections that are a huge burden on public health and global agriculture. 
2) From the heme microarrays, there were two genes, hrg-1 and the paralog hrg-
4, that were highly upregulated at low heme conditions. While hrg-4 is 
specific to worms, hrg-1 has homologs in vertebrates. Amino acid sequence 
comparison revealed that these genes have conserved amino acids, including 
histidines in TMD2 and the E2 loop and a FARKY motif in the C-terminus 
that might interact with the propionate side chains of heme. 
3) Depletion of hrg-1 by RNA-mediated interference resulted in increased GFP 
fluorescence in the “heme-sensor” IQ6011 strain at a heme concentration of 5 
μM and increased ZnMP fluorescence. Depletion of hrg-4 resulted in 
increased GFP fluorescence in the IQ6011 sensor strain in conditions where 
heme was in excess (25 μM), decreased ZnMP fluorescence and resistance to 
GaPPIX toxicity. These results indicate that knock-down of these genes lead 
to aberrant heme homeostasis. In addition the ZnMP staining pattern provides 
a clue to the intracellular localization, i.e. HRG-4 participated in heme uptake 
at the plasma membrane in the polarized intestinal cells of the worm while 
HRG-1 was involved in intracellular compartmentalization. 
4) Ectopic expression in mammalian cells showed that HRG-4 localized to the 
plasma membrane and HRG-1 co-localized with endosomal (Rab 7 and Rab 
11) and lysosomal markers (LAMP1). Human HRG-1 (SLC48A1) co-
localized with CeHRG-1 greater than 80% of the time.  
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5) Amino acid sequence analysis reveals trafficking motifs within the C-terminus 
of worm and human HRG-1. A conserved tyrosine (YxxxØ in humans and 
YxxØ in worms) and acidic-dileucine (DxxIL in humans and ExxxLL in 
worms) based sorting motifs were found in HRG-1 but were absent in HRG-4. 
This observation is consistent with the localization studies because the 
tyrosine and acidic-dileucine based sorting motifs have been shown to be 
involved in targeting of proteins to endosomes and lysosome-related 
organelles.  
6) HRG-4 bound heme over a broader pH range as compared to HRG-1 (both 
worm and human), which bound heme better only at lower pH. Thus, the 
studies corroborate the intracellular location and function of HRG-1 within an 
acidic compartment.   
7) Injection of cRNA for Cehrg-1, hHRG1 or Cehrg-4 into Xenopus oocytes 
resulted in significant heme-mediated inward currents. Given that HRG-1 
proteins are permeases, it is likely that these transporters may translocate the 
negatively charged heme coupled to a pre-established ionic gradient.  An 
example of a counter-ion would be the Na+ gradient established by the Na/K 
ATPase at the plasma membrane.  Nevertheless, our results clearly indicate 
that HRG-1 and HRG-4 function as transporter across membranes.  
8) To understand the role of HRG-1 proteins in mediating heme homeostasis, 
morpholinos were used to knock-down zebrafish hrg-1. Zebrafish has been 
used extensively as a model organism to study hematopoiesis because the 
embryos are transparent and have a beating heart and visible erythrocytes by 
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24 hpf. While a reduction in hrg-1 led to mild anemia as demonstrated by the 
MO1 phenotypes, a severe knock-down of hrg-1 resulted in a striking anemic 
phenotype with developmental defects, including a curved body with 
shortened yolk sac and hydrocephalus. The lack of any developmental defects 
in worms depleted of hrg-1 or hrg-4 might be due to incomplete RNAi or 
other compensatory mechanisms. HRG-1 is important for the maintenance and 
hemoglobinization of hematopoietic cells in zebrafish and not for cell type 
specification. Importantly, the worm ortholog fully rescued all the genetic 
defects due to knock-down of zebrafish hrg-1. 
9) Cehrg-4 has two other paralogs, hrg-5 and hrg-6, that were not heme-
responsive. The identification of these other paralogs suggests that there might 
be redundant mechanisms for heme uptake and transport in worms. This could 
explain why we did not observe any discernable developmental phenotypes 
due to hrg-1 and hrg-4 depletion in worms.  
10) In worms, both HRG-1 and HRG-4 are found in the intestinal cells. The two 
proteins have very different localization patterns. HRG-4 is found on the 
lumenal surface while HRG-1 localized to vesicles found in the intestinal 
cells. 
11)  Analysis of ∆hrg-1 (tm3199) and ∆hrg-4 (tm2994) worm strains revealed that 
the ∆hrg-1 strain is a null mutant and the ∆hrg-4 strain expresses a truncated 
form of hrg-4 mRNA and may, therefore, be a hypomorph. Results from 
ZnMP uptake and GaPPIX toxicity assays in the deletion worms were 
contradictory to our results observed from hrg-1 or hrg-4 RNAi in N2 worms. 
 152 
 
It is possible that even after eight backcrosses, the animals are still carrying 
other spurious deletions. This is demonstrated by the differences in hrg-1, -4, -
5 and -6 gene expression in the brood mate controls. Another reasonable 
argument is that the deletion strains are upregulating other mechanisms of 
heme uptake and transport to compensate for the loss of hrg-1 or hrg-4.  The 
recent availability of a Mos transposon insertion line in the hrg-4 locus 




The goals of this dissertation were to identify genes that are transcriptionally 
regulated by heme and to characterize the role of one or more genes in mediating 
heme homeostasis. Prior to this work, the presence of molecules involved in intestinal 
heme uptake and transport of heme from the mitochondria where it is synthesized to 
other cellular compartments where hemoproteins reside has been widely speculated. 
The identification of such molecules has been stymied by the inability to dissociate 
the tightly regulated processes of heme biosynthesis and degradation from heme 
uptake and intracellular transport. C. elegans provided the unique opportunity to 
modulate intracellular heme levels by changing environmental heme levels in the 
liquid growth medium. 
 This dissertation provides, for the first time, insights into the mechanisms of 
heme uptake and transport in eukaryotes. The studies performed in this body of work 
using C. elegans as an animal model of heme auxotrophy, certainly provide a starting 
point for such nutrient-gene interaction studies, the results of which can then be 
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extrapolated to other vertebrates including mammals. The tools and reagents 
developed during the course of this dissertation will be useful to address some of the 
critical questions related to heme uptake, transport and sequestration but also 
questions regarding the mechanisms by which the heme moiety is incorporated into 
hemoproteins. 
Future studies 
In vivo analysis of HRG-1 proteins 
While detailed studies have been conducted to characterize the role of HRG-1 
and HRG-4 in mediating heme homeostasis, not much is known about the role of 
HRG-5 and HRG-6. We postulate that, since worms rely solely on exogenous heme 
for their growth and development, they have additional mechanisms for heme 
acquisition that might include HRG-5 and HRG-6. Therefore, spatial and temporal 
expression patterns, along with the intracellular location need to be determined for 
HRG-5 and HRG-6. Functional assays including heme-binding studies need to be 
performed to understand the role that these paralogs might play in heme homeostasis. 
Interestingly, while cloning hrg-5, we observed that there were discrepancies between 
the genomic DNA and the cDNA sequences. Further studies conducted on hrg-5 in 
worms suggest that this gene might undergo RNA editing (Xiaojing Yuan and Iqbal 
Hamza, unpublished observations). Investigating the effects of heme on hrg-5 editing 
and analyzing hrg-5 genomic DNA and mRNA in the C. elegans ADAR mutants 
(Adenosine deaminase acting on RNA; this enzyme is responsible for the conversion 
of adenosines to inosines) will provide a better understanding of the post-
transcriptional control of hrg-5 [169].  
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The different localization pattern of HRG-1 and HRG-4 proteins has raised 
questions about how these paralogs might be regulated. Jason Sinclair, a graduate 
student in the lab, is conducting experiments to identify cis-elements that might be 
involved in the heme-mediated transcriptional regulation of hrg-1 and hrg-4. Scott 
Severance, a post-doctoral fellow, has undertaken a genome-wide RNAi analysis 
looking for modulators of hrg-1::gfp expression in the “heme-sensor” strain in the 
presence and absence of heme. He has already identified 53 modulators of heme 
homeostasis by performing an RNAi screen using all the hrgs that were identified 
from the heme microarrays. This analysis may reveal novel molecules involved in 
organismal heme homeostasis. 
Transgenic lines stably expressing hrg-4::yfp translational reporter constructs 
with either the unc-54 3’ UTR or the hrg-4 3’ UTR were generated. While lines 
containing the translational construct with hrg-4 3’ UTR had YFP expression, there 
was no fluorescence in the worms expressing hrg-4::yfp with unc-54 3’ UTR. This 
observation is preliminary, but it suggests that the 3’ UTR might be important for the 
regulation of hrg-4. It has been shown before that 3’ UTRs are important for the 
down regulation of mRNA levels [170].  
These findings reveal the possibility of a complex regulatory circuit involving 
hrg paralogs. The differences in regulation of individual hrgs could provide 




Structure-function analysis of HRG-1 proteins 
As mentioned above, there are conserved residues shared between the 
CeHRG-1 and CeHRG-4 proteins. One such motif is the FARKY motif, which might 
be involved in stabilizing the heme moiety by interacting with the propionate side 
chains [153, 155, 171]. Human and the worm HRG-1 proteins have an invariant 
histidine in TMD 2 and the E2 loop and tyrosine- and acidic-dileucine-based sorting 
motifs at the C-terminus. Studies are underway to delineate the structural elements 
that are important for localization and function of HRG-1 proteins. For example, 
domain-swapping experiments done by Caitlin Hall revealed that the C-terminus of 
HRG-1 is important for its localization to endo-lysosomal compartments. Xiaojing 
Yuan is using PCR-based site-directed mutagenesis to mutate the conserved residues 
to alanine. These constructs will then be examined for differences in their 
intracellular localization patterns and heme transport abilities.  
 The HRG-1 and HRG-4 proteins share some of the features of tetraspanins 
including cysteines in the transmembrane domains that are important for membrane-
proximal palmitoylation. It will be interesting to mutate the cysteine residues in the 
TMDs of these proteins and analyze the stability of the HRG-1 proteins. Tetraspanins 
are found in small microdomains called tetraspanin-enriched microdomains (TEM) 
[164]. A main biochemical feature of the TEM is that it is resistant to non-
denaturating detergent treatments, a feature that has been observed for HRG-1 
proteins. An interesting experiment would be to deplete cholesterol from the cells and 
then analyze the oligomerization pattern of HRG-1 proteins. 
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Identification of interacting partners 
Heme uptake and transport in bacteria have been shown to involve complex 
molecular networks. Hence, we speculate that the HRG-1 proteins might also be a 
part of an elaborate network of molecules regulating heme uptake, transport and 
storage. To identify these additional molecules, genome-wide RNA-mediated 
interference assay will be performed in the strain IQ6111 (transgenic worms stably 
expressing hrg-1::gfp translational construct) to detect aberrant localization of HRG-
1::GFP and/ or ZnMP. The genetic interaction between the candidate genes from the 
RNAi assay and either hrg-1, hrg-4, or both can be studied using the hrg-1 and hrg-4 
single and double mutants. Furthermore, transcriptional profiling experiments of the 
hrg-1 and hrg-4 deletion animals grown under different heme concentrations might 




There are still many unanswered questions. What is the physiologically 
relevant ligand for these proteins? Haptoglobin, hemopexin, serum albumin and 
lipoproteins (HDL and LDL) have been shown to physiologically sequester heme 
[172]. It would not be surprising if protein-bound heme is the ligand for HRG-1 
proteins. How do these proteins function? It is possible that these proteins might 
function similarly to lac permeases in that the transport of heme could be coupled to a 
proton gradient [173]. This hypothesis can be tested by depleting the 19 V-type 
ATPases (these proteins have been shown to actively transport protons into organelles 
and extracellular compartments thereby generating a proton gradient) by RNAi in 
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IQ6111 worms and analyze the differences in localization of HRG-1::GFP and/or 
ZnMP uptake [174]. What is the role of human HRG-1 in mediating heme 
homeostasis? It has been shown that some of the heme released within the 
macrophages after phagocytosis of senescent red blood cells can be exported by 
FLCVR [88]. Although the fate of this exported heme is unclear, it is likely that it is 
being sequestered in an acidic compartment. This is a reasonable argument because it 
has been suggested that sequestration of metals or metal-containing groups such as 
heme in acidic compartments such as lysosomes may help avoid their toxic effects 
[175]. There is also evidence supporting the involvement of lysosomes in the 
recycling pathways for metals such as iron. A study conducted by Radisky and 
Kaplan has demonstrated that lysosomal degradation of ferritin is one of the 
mechanisms by which iron can reutilized [176]. The results from their study also 
suggest the possibility of soluble iron being stored in the lysosomes. We have shown 
that HRG-1 localizes to acidic endo-lysosomal compartments. So it might be possible 
that when there is a huge demand for heme, such as in developing erythrocytes, HRG-
1 mobilizes free heme out of these acidic compartments. It is also likely that HRG-1 
may be involved in intercellular transport of heme by redistributing heme from heme-
rich tissues (red blood cells, bone marrow and liver) to other tissues with a greater 
requirement for heme transiently during embryonic and organ development. This 
argument is reasonable because loss of function of HRG-1 in zebrafish causes severe 








HRG-1 is essential for erythropoiesis in zebrafish 
a) Zebrafish hrg-1 expression in  the 15-somite stage (left) and 24 h after fertilization 
(right). b) Knockdown of zebrafish hrg-1 by using morpholinos MO1 and MO2 
against zebrafish hrg-1 results in either mild (MO1) or severe anemia (MO2) with 
very few o-dianisidine-positive red cells (arrows, right panel), hydrocephalus, curved 
body and shortened yolk sac (arrows, left panel). c) Schematic representation of 
zebrafish hrg-1 genomic structure indicating the locations of MO1 and MO2 
morpholinos and primers used for RT-PCR analysis. d) RNA extracted from embryos 
injected with MO1 and MO2 was used to perform RT-PCR. Left panel- top arrow 
indicates the misspliced mRNA isoform generated by MO1. Right panel- bottom 
arrow indicates the product of exon skipping generated by MO2.  Cehrg-1 cRNA 
injected along with MO2 rescues anemia as indicated by an increase in o-dianisidine-
positive red cells (e) and completely rescues the developmental defects (f, arrows) 
Julio Amigo and Barry Paw conducted the studies in zebrafish. 


















Appendix B  
 
HRG-1 proteins bind heme 
 Cell lysates (lanes 1 and 4, one-tenth of total protein) from HEK 293 cells transfected 
with plasmids expressing either CeHRG-4 (60 μg), CeHRG-1 (60 μg), hHRG1 (60 
μg) or hZIP-4 (360 μg) tagged with the HA epitope were incubated with 300 nmol of 
heme agarose. Samples were resolved by SDS-PAGE, transferred to nitrocellulose 
and detected with antibodies against the HA epitope. Wash (lanes 2 and 5) represents 
the final wash before elution (lanes 3 and 6). Samples were resolved by SDS-PAGE 
followed by immunoblotting with anti-HA antibody.   
(Anita Rao and Iqbal Hamza performed the heme binding experiment) 






Appendix C  
 
HRG-1 proteins transport heme 
Electrophysiological currents (mean ± S.D., n = 4) from Xenopus oocytes injected 
with cRNA encoding the indicated protein when clamped at -110 mV in the presence 
of 20 μM heme. Y-axis represents the difference in the current in the presence and 
absence of heme, normalized to current observed in the absence of heme. Values with 
different letter labels are significantly different within each treatment compared to 
control, hKv1.1 (P< 0.05). 
(Sanjeev.K.Upadhyay and M.Matthew conducted the transport studies in Xenopus) 








qRT-PCR primers and primers for screening of hrg-1 and hrg-4 deletion strains. 
 
 














































Worm strains and their descriptions. 
Name Construct Vector
IQ 6011 hrg-1  promoter pPD95.67
IQ 6041 hrg-4 PRM::NLSGFP::hrg-4  3' UTR pDESTR4R3
IQ 6111 hrg-1  PRM::hrg-1  gene+ gfp  gene::hrg-1  3' UTR pDESTR4R3
IQ 6141 hrg-4  PRM::hrg-4 gene+yfp  gene::hrg-4  3' UTR pDESTR4R3
IQ 6909 brood mate for hrg-4  homozygous deletion worms none
IQ 6910 hrg-4  homozygous deletion none
IQ 6911 brood mate for hrg-1  homozygous deletion worms none
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